Skip to main content
eLife logoLink to eLife
. 2023 Aug 7;12:e88875. doi: 10.7554/eLife.88875

Saccharomyces cerevisiae DJ-1 paralogs maintain genome integrity through glycation repair of nucleic acids and proteins

Gautam Susarla 1, Priyanka Kataria 1,, Amrita Kundu 1,, Patrick D'Silva 1,
Editors: Agnieszka Chacinska2, Detlef Weigel3
PMCID: PMC10431920  PMID: 37548361

Abstract

Reactive carbonyl species (RCS) such as methylglyoxal and glyoxal are potent glycolytic intermediates that extensively damage cellular biomolecules leading to genetic aberration and protein misfolding. Hence, RCS levels are crucial indicators in the progression of various pathological diseases. Besides the glyoxalase system, emerging studies report highly conserved DJ-1 superfamily proteins as critical regulators of RCS. DJ-1 superfamily proteins, including the human DJ-1, a genetic determinant of Parkinson’s disease, possess diverse physiological functions paramount for combating multiple stressors. Although S. cerevisiae retains four DJ-1 orthologs (Hsp31, Hsp32, Hsp33, and Hsp34), their physiological relevance and collective requirement remain obscure. Here, we report for the first time that the yeast DJ-1 orthologs function as novel enzymes involved in the preferential scavenge of glyoxal and methylglyoxal, toxic metabolites, and genotoxic agents. Their collective loss stimulates chronic glycation of the proteome, and nucleic acids, inducing spectrum of genetic mutations and reduced mRNA translational efficiency. Furthermore, the Hsp31 paralogs efficiently repair severely glycated macromolecules derived from carbonyl modifications. Also, their absence elevates DNA damage response, making cells vulnerable to various genotoxins. Interestingly, yeast DJ-1 orthologs preserve functional mitochondrial content, maintain ATP levels, and redistribute into mitochondria to alleviate the glycation damage of macromolecules. Together, our study uncovers a novel glycation repair pathway in S. cerevisiae and a possible neuroprotective mechanism of how hDJ-1 confers mitochondrial health during glycation toxicity.

Research organism: S. cerevisiae

Introduction

The structural and functional integrity of nucleic acids and proteins is critical for establishing a physiological balance to maintain normal cellular health. Reactive carbonyl species (RCS) are highly toxic compounds that covalently bind and damage vital cellular components such as protein, DNA, and fatty acids (Semchyshyn, 2014). RCS primarily constitutes methylglyoxal (MG), glyoxal (GO), and 3-deoxyglucosone (Semchyshyn, 2014). The MG and GO are metabolic by-products of reactive aldehyde and ketones, respectively (Allaman et al., 2015; Lange et al., 2012). At the basal physiological level, these dicarbonyls participate in numerous signaling processes essential for cellular development and stress response (Akhand et al., 2001; Rodrigues et al., 2020). On the contrary, MG and GO modifies the thiol and amine groups at elevated levels through the Maillard reaction, forming a myriad of irreversible intermediates followed by stable Advanced glycation end-products (AGEs; Semchyshyn, 2014; Thornalley, 2008). They preferentially form adducts with side chains of arginine, lysine, and cysteine and indiscriminately impair the structure and function of proteins. Moreover, the glycation of essential proteins, including antioxidant machinery, can alter reactive oxygen species (ROS) homeostasis, mitochondrial performance, and proteostasis (Goudarzi et al., 2018; Seo et al., 2014). Likewise, chronic exposure of nucleic acids to RCS culminates into nucleotide AGEs that promote genetic aberrations and translational defects and induce a spectrum of mutations, including transition and G: C to T: A transversions (Murata-Kamiya et al., 1997; Murata-Kamiya et al., 2000). Elevated glycation of protein and DNA has implications for several pathologies like diabetes, aging, and neurodegenerative diseases (Fournet et al., 2018). Therefore, regulating endogenous RCS and minimizing its detrimental effects on biomolecules is critically important. The glyoxalase system that constitutes glyoxalase I and II efficiently detoxifies MG and GO to D-lactate and glycolate by utilizing glutathione (GSH) as a cofactor (Inoue et al., 2011). Since excess levels of carbonyls concomitantly induce ROS, the GSH pool is rapidly depleted during the anti-oxidation process (de Bari et al., 2020). Hence, cells have evolved GSH independent pathway (glyoxalase III system) to maintain a healthy redox balance, primarily comprising DJ-1/ThiJ/Pfp1 superfamily proteins (Bankapalli et al., 2015; Lee et al., 2012; Melvin et al., 2017).

DJ-1 superfamily members are highly conserved, multi-stress responding, and ubiquitously present in most organisms (Bandyopadhyay and Cookson, 2004; Wei et al., 2007). The superfamily includes human DJ-1(hDJ-1/PARK7), a well-explored protein that induces a familial form of Parkinson’s disease (PD) through its genetic mutations (Bonifati et al., 2003). Besides having various neuroprotective functions, hDJ-1 possesses methylglyoxalase and glyoxalase activity that substantially modulates endogenous carbonyls (Lee et al., 2012). Moreover, the deletion of E. coli DJ-1 members exhibited alterations in the glycation of DNA and proteins (Lee et al., 2016; Richarme et al., 2017). Saccharomyces cerevisiae has four homologs of DJ-1, namely Hsp31, Hsp32, Hsp33, and Hsp34, representing Hsp31 mini-family proteins (Wilson et al., 2004). Interestingly, Hsp32, Hsp33, and Hsp34 share ~99.5% sequence identity within them and ~70% sequence identity with Hsp31. All the paralogs possess a common catalytic triad constituting Cys138, His139, and Glu170. A characteristic hallmark of DJ-1 superfamily members is the redox-sensing catalytic cysteine, whose oxidation state determines the physiological function (Wilson, 2011). The emerging evidence on bacteria, humans, and plant DJ-1 members reveals a unique deglycase machinery that relieves the MG and GO glycation adducts on DNA and proteins (Prasad et al., 2022; Richarme et al., 2017; Smith et al., 2022). This repair mechanism is further appreciated in preventing protein aggregation and altering the epigenetic landscape of the chromatin (Sharma et al., 2019; Zheng et al., 2019). Some S. cerevisiae Hsp31 members are reported to possess crucial functions in regulating ROS, mitochondrial dynamics, and chaperone activity (Aslam et al., 2016; Bankapalli et al., 2020; Miller-Fleming et al., 2014; Tsai et al., 2015). However, the biological relevance of having multiple DJ-1 orthologs in S. cerevisiae is poorly understood due to the lack of in vitro evidence and difficulties in targeting specific paralog as they are genetically almost identical.

In the current report, we have uncovered a primary role of the Hsp31 paralogs as glyoxalases and protectants of the genome and mitochondria against RCS. By, governing endogenous dicarbonyl levels, they prevent macromolecular glycation and abrogate genetic mutations. In response to glycation stress, mRNA translation activity was significantly reduced in the absence of yeast DJ-1 members. Furthermore, the novel deglycase machinery efficiently repairs glycated DNA and proteins, substantially reverting deleterious alterations on biomolecules. We also show that Hsp31 paralogs impart enhanced mitochondrial integrity by maintaining functional mitochondria content, sustained ATP levels, and attenuating glycation stress on mitochondria through redistribution. Together, the dual role is critical in providing multifaceted protection to cellular and organellar macromolecules during persistent carbonyl stress.

Results

Deletion of Hsp31 paralogs aggravates carbonyl toxicity and induces proteome glycation

The DJ-1 superfamily members strongly relate to regulating dicarbonyl stress primarily through scavenging excess intracellular MG and GO (Lee et al., 2012; Subedi et al., 2011). However, despite being conserved, the biological significance of S. cerevisiae Hsp31 paralogs is uncharacterized in the presence of carbonyl toxicity. Although the paralogs have very similar amino acid sequences, we utilized the ease of genetic manipulation in yeast to unravel their association with the homeostasis of RCS (Figure 1—figure supplement 1A). Hsp31 paralogs were sequentially deleted in the WT background in multiple combinations such as Δhsp3131) to Δhsp3434), Δ31Δ32 to Δ31Δ34, Δ31Δ32Δ33T), and Δ31Δ32Δ33Δ34Q) which simplifies the comprehensive understanding of the individual genes. As glyoxalase-1 (GLO1) extensively modulates endogenous RCS levels, Δglo1 strain was used for comparative analysis (Gomes et al., 2005). Phenotypic analyses under GO stress revealed a mild growth sensitivity in single deletion strains (Figure 1A, compare panels glyoxal (GO) with control), and the viability was further affected in Δ31Δ32, Δ31Δ33, and Δ31Δ34. Interestingly, ΔT and ΔQ displayed synergistic worsening of growth compared to other strains, inferring their additive overlapping functions during GO toxicity. Subsequently, the effect of MG stress was tested in the deletion background of Hsp31 members. Among the paralogs, Δ31 alone displayed mild growth sensitivity, as reported earlier (Figure 1A, compare panels methylglyoxal (MG) with control; Bankapalli et al., 2015). On the other hand, additional loss of Hsp32, Hsp33, and Hsp34 in Δ31 had no cumulative effect on viability.

Figure 1. Deletion of Hsp31 paralogs induces protein glycation.

(A) Yeast phenotypic analysis. Cells were grown until the mid-log phase and harvested, subsequently treated with 10 mM MG before being spotted or spotted on YPD medium plates containing 15 mM GO. The plates were incubated at 30 °C and imaged at 36 hr. (B, C) Proteome glycation profile. Yeast strains were treated with 15 mM GO in the YPD culture medium and allowed to grow for 12 hr, followed by western analysis with anti-CML antibody. (D, E) MAGE detection by western blotting. Cells from the mid-log phase were incubated with 10 mM MG for 12 hr, and MAGE levels were estimated using an anti-MAGE antibody. Protein glycation levels were determined by measuring the whole lane intensities by densitometry and plotted with respect to WT. The blots stained with Ponceau S were used as the loading control. One-way ANOVA with Dunnet’s multiple comparisons test was used to determine significance from three independent biological replicates, *, p≤0.05; **, p≤0.01; ***, p≤0.001; NS, not significant.

Figure 1—source data 1. Source data for Figure 1B contains raw image of western blot and densitometric values for graph.
Figure 1—source data 2. Source data for Figure 1C contains raw image of western blot and densitometric values for graph.
Figure 1—source data 3. Source data for Figure 1D contains raw image of western blot and densitometric values for graph.
Figure 1—source data 4. Source data for Figure 1E contains raw image of western blot and densitometric values for graph.

Figure 1.

Figure 1—figure supplement 1. Amino acid sequence alignment of Hsp31 paralogs and protein glycation profile in the absence of GO stress.

Figure 1—figure supplement 1.

(A) Amino acid sequences of Hsp31 paralogs were aligned using the online tool Clustal Omega. Black shade indicates identical amino acids. Red boxes indicate amino acids of the catalytic triad. (B, C) Respective strains were grown till the stationary phase and subsequently lysed. The protein glycation levels were estimated by immunodetection using anti-CML antibody.
Figure 1—figure supplement 1—source data 1. Source data for Figure 1—figure supplement 1B contains raw image of western blot.
Figure 1—figure supplement 1—source data 2. Source data for Figure 1—figure supplement 1C contains raw image of western blot.

To test whether the observed phenotypes are the consequence of impaired carbonyl homeostasis, protein modifications were examined in the deletion background of Hsp31 paralogs. To determine the GO and MG-induced alterations, anti-CML (carboxymethyl-lysine) and anti-MAGE (methylglyoxal AGE) antibodies were utilized to determine the intermediates of AGEs, respectively. The basal physiological glycation levels (absence of glycation stress) in ΔQ strain displayed an increment in GO-modified proteins compared to Δglo1 strain suggesting Hsp31 paralogs are essential for the RCS detoxification in vivo (Figure 1—figure supplement 1B, C). However, such basal glycation levels are tolerable to the cells without exhibiting growth sensitivity. Intriguingly, upon subjecting to additional external glycation stress, a significant elevation of CML levels was observed in the single mutants compared to WT (Figure 1B). At the same time, the deletion of additional members substantially further exacerbated the modifications. It cumulatively enhanced the protein glycation levels to a greater extent in ΔT and ΔQ than Δglo1, consistent with growth sensitivity (Figure 1C). In contrast, the effect of MG-induced glycation was restricted to Δ31 with a subtle increment of MAGE levels compared to WT, consistent with growth sensitivity in the presence of MG (Figure 1D and compare growth in the last panels, Figure 1A). Intriguingly, the collective loss of the members did not exhibit additional MAGE modification in agreement with the growth sensitivity in the presence of MG (Figure 1E and compare growth in the last panels, Figure 1A). This preliminary data demonstrate that yeast DJ-1 members act on specific RCS and collectively provide superior tolerance towards GO toxicity than the GLO1. Strikingly, Hsp31 alone imparts resistance for both GO and MG, preventing the persistent ongoing protein glycation.

The absence of Hsp31 paralogs enhances nucleic acid glycation and abates mRNA translation efficiency

The nucleic acids are highly susceptible to modifications and are constantly challenged with several metabolic by-products that elicit mutations and chromosomal aberrations (Chatterjee and Walker, 2017). Occasionally, the alterations are irreversible and may not be repaired despite stringent repair systems, culminating to disease conditions. Since the absence of Hsp31 paralogs augments protein glycation, the glycation status of cellular nucleic acids was also assessed. Despite the absence of GO stress, DNA glycation levels were elevated in both ΔT and ΔQ (Figure 2—figure supplement 1A, B). However, in the presence of GO stress, the single deletion strains exhibit further enhancement in the glycation compared to WT (Figure 2A). At the same time, the additional loss of Hsp31 paralogs led to a synergistic increment of DNA adducts, most evident in ΔT and ΔQ strains consistent with the growth sensitivity (Figure 2B).

Figure 2. Loss of Hsp31 paralogs aggravates the glycation of DNA and RNA, affecting translational activity.

(A, B) Immunodetection of DNA using dot-blot assay. Three µg of total genomic DNA from respective strains treated overnight with 15 mM GO was dotted on nitrocellulose membrane and probed with anti-CML antibody. (C, D) RNA glycation profile. Global RNA extracted from cells incubated with 15 mM GO were dotted and analyzed using anti-CML antibody. (E) Polysome profiling. Untreated (-GO) and treated (+GO) WT and ΔQ cells with GO were subjected to polysome profiling. (F) Ratio of polysomes to monosomes (P/M). The area occupied by the polysome and the monosome peak was determined using Origin 8.0 for the respective samples, and the ratios were plotted. WT (+GO) was compared with WT (-GO), and ΔQ (-GO) was compared with ΔQ (+GO). (G–J) Estimation of MAGE-modified nucleic acids. Strains lacking Hsp31 paralogs were treated with 10 mM MG for 12 hr, and the genomic DNA and RNA were dotted on the membrane and probed with anti-MAGE antibody. The relative intensity of dots representing the glycation levels was calculated and compared to WT. One-way ANOVA with Dunnet’s multiple comparisons test was used to determine significance from three independent biological replicates, *, p≤0.05; **, p≤0.01; ***, p≤0.001; NS, not significant.

Figure 2—source data 1. Source data for Figure 2A contains raw image of western blot and densitometric values for graph.
Figure 2—source data 2. Source data for Figure 2B contains raw image of western blot and densitometric values for graph.
Figure 2—source data 3. Source data for Figure 2C contains raw image of western blot and densitometric values for graph.
Figure 2—source data 4. Source data for Figure 2D contains raw image of western blot and densitometric values for graph.
Figure 2—source data 5. Source data for Figure 2E contains densitometric values for graph.
Figure 2—source data 6. Source data for Figure 2F contains densitometric values for graph.
Figure 2—source data 7. Source data for Figure 2G contains raw image of western blot and densitometric values for graph.
Figure 2—source data 8. Source data for Figure 2H contains raw image of western blot and densitometric values for graph.
Figure 2—source data 9. Source data for Figure 2I contains raw image of western blot and densitometric values for graph.
Figure 2—source data 10. Source data for Figure 2J contains raw image of western blot and densitometric values for graph.

Figure 2.

Figure 2—figure supplement 1. Glycation profile of DNA in the absence of GO stress.

Figure 2—figure supplement 1.

(A, B) DNA extracted from stationary phase cells was dotted (3 µg) on nitrocellulose membrane and probed with anti-CML to determine the glycation status.
Figure 2—figure supplement 1—source data 1. Source data for Figure 2—figure supplement 1A contains raw image of western blot.
Figure 2—figure supplement 1—source data 2. Source data for Figure 2—figure supplement 1B contains raw image of western blot.

Besides the alterations in DNA, the glycation of RNA was also determined, as its modifications lead to ribosome stalling, translational defects, and inefficient binding with proteins (Mitchell et al., 2018; Zheng et al., 2020). Like DNA, the lack of Hsp31 paralogs led to the high frequency of RNA modifications, which were quantitatively higher than Δglo1 (Figure 2C and D). Furthermore, the effect of glycation toxicity on global mRNA translational activity was evaluated between WT and ΔQ. In the absence of GO stress, WT and ΔQ showed similar polysome profiles (Figure 2E). However, the mRNA translational activity was significantly reduced in ΔQ treated with GO, as indicated by low-intensity polysome peaks (Figure 2E). The ratio of polysome to monosomes also suggested a reduced translation rate in ΔQ compared to WT in the presence of glycation stress (Figure 2F).

Next, the role of yeast DJ-1 orthologs in maintaining genome integrity was investigated during MG stress. Unlike Δ31, the DNA glycation in Δ32, Δ33, and Δ34 was minimally detected by α-MAGE (Figure 2G), inferring their lack of participation in MG detoxification. Further, the paralogs were cumulatively deleted to evaluate the possibility of additive effects on glycation levels. Interestingly, the MAGE-modified DNA was restricted to the loss of Hsp31 due to its role in MG homeostasis (Figure 2H). Also, deletion of Hsp31 alone led to substantial glycation of RNA when treated with MG (Figure 2I and J). In summary, our results highlight that the DJ-1 paralogs in yeast play an essential role in modulating the RCS-mediated glycation of DNA and RNA.

Yeast DJ-1 orthologs are robust glyoxalases that attenuate the glycation of macromolecules

DJ-1 superfamily members are reported to detoxify MG and GO independently by the same active site with varying kinetics (Bankapalli et al., 2015; Lee et al., 2012). Hence, to establish a direct correlation of enhanced glycation with excess intracellular RCS, Hsp31 paralogs were purified using affinity chromatography (Figure 3—figure supplement 1A). Our in vitro enzyme activity assay suggested that Hsp31, Hsp32, Hsp33, and Hsp34 possess a robust glyoxalase activity compared to BSA, which served as negative control (Figure 3A). Furthermore, the kinetic parameters indicate that paralogs have relative catalytic efficiencies. Notably, the paralogs exhibited fourfold higher kcat for glyoxalase activity than hDJ-1 (Lee et al., 2012; Figure 3B and Figure 3—figure supplement 1B). To further appreciate their in vivo biological response during GO stress, Hsp31 members were overexpressed within ΔQ strain and observed a substantial rescue in the growth similar to WT (Figure 3C). The expression of the proteins was normalized to equal amounts (Figure 3—figure supplement 1C).

Figure 3. Hsp31 paralogs prevent glyoxal toxicity.

(A) Measurement of the glyoxalase activity in vitro. 5 µg of purified Hsp31 paralogs were incubated with 0.5 mM GO, and the absorbance was monitored at 570 nm. (B) Estimating the kinetic parameters of the enzyme. The kinetic efficiency was determined by calculating their relative velocities against multiple GO concentrations. (C) Growth phenotypic analysis. WT and ΔQ overexpressing Hsp31 paralogs were grown until the mid-log phase, spotted on SD Leu- media plates containing 15 mM GO, and incubated at 30 °C. (D) Yeast DJ-1 homologs alleviate proteome glycation. Respective strains were grown in SD Leu- culture tubes and treated with 15 mM GO for 12 hr, and the whole cell lysates were processed and probed for CML modifications. (E, F) Analysis of nucleic acid modifications by dot-blot assay. Genomic DNA and global RNA extracted from cells treated with 15 mM GO were dotted on the membrane and detected with anti-CML antibody. (G) C138 amino acid residue is essential for glyoxalase activity. All the proteins were purified and incubated (5 µg) with 0.5 mM GO; subsequently, the absorbance was monitored at 570 nm. BSA was used as negative control in enzymatic assay. Glycation levels represent the relative intensities of the dots and lanes compared with WT. Data from three independent biological replicates was used to determine significance through one-way ANOVA with Dunnet’s multiple comparisons test *, p≤0.05; **, p≤0.01; ***, p≤0.001; NS, not significant.

Figure 3—source data 1. Source data for Figure 3A contains densitometric values for graph.
Figure 3—source data 2. Source data for Figure 3B contains densitometric values for graph.
Figure 3—source data 3. Source data for Figure 3D contains raw image of western blot and densitometric values for graph.
Figure 3—source data 4. Source data for Figure 3E contains raw image of western blot and densitometric values for graph.
Figure 3—source data 5. Source data for Figure 3F contains raw image of western blot and densitometric values for graph.
Figure 3—source data 6. Source data for Figure 3G contains densitometric values for graph.

Figure 3.

Figure 3—figure supplement 1. Enzyme kinetics of yeast DJ-1 orthologs and their expression under GO stress.

Figure 3—figure supplement 1.

(A) SDS-PAGE of purified Hsp31 paralogs. 7 µg of Hsp31 paralogs were loaded on SDS-PAGE gel along with the protein marker (M). (B) Raw values of enzyme kinetics. GO was incubated at various concentrations with 5 µg Hsp31 paralogs, and the reaction was terminated at different time intervals. The corresponding readings were plotted on Prism GraphPad 5.0 and calculated for Km, kcat, and Vmax. (C) Hsp31 members expressed under the plasmid pRS415GPD in ΔQ, confirmed with western analysis. (D, E) GO-induced expression of Hsp31 paralogs. Cells expressing Hsp31 members with genomic tagged HA were incubated without or with 15 mM GO for 12 hr, and the expression was determined by immunoblotting with an anti-HA antibody. Gel stained with Coomassie brilliant blue (CBB) was used as a loading control. The fold change in the expression was calculated using Multi-Gauge V3.0 and plotted in Prism GraphPad 5.0. The experiments were performed in three independent biological replicates and statistically analysed by paired t-test, *, p≤0.05; **, p≤0.01; ***, p≤0.001; NS, not significant.
Figure 3—figure supplement 1—source data 1. Source data for Figure 3—figure supplement 1A contains raw image of SDS-PAGE.
Figure 3—figure supplement 1—source data 2. Source data for Figure 3—figure supplement 1C contains raw image of western blot.
Figure 3—figure supplement 1—source data 3. Source data for Figure 3—figure supplement 1D contains raw image of western blot.
Figure 3—figure supplement 1—source data 4. Source data for Figure 3—figure supplement 1E contains densitometric values for graph.

To further corroborate the above findings, ΔQ strain overexpressing Hsp31 paralogs was subjected to GO stress and probed for CML levels. In agreement with our data, the modifications on proteins and nucleic acids were substantially suppressed in the presence of yeast DJ-1 glyoxalase machinery (Figure 3D–F). Next, the role of nucleophile cysteine amino acid (Cys-138) in the glyoxalase activity was tested, as its mutation predominantly impair the functions of DJ-1 members (Bankapalli et al., 2015; Lee et al., 2012; Zheng et al., 2019). Therefore, cysteine 138 was replaced with alanine (C138A), and the proteins were subjected to the glyoxalase activity assay. Upon in vitro analysis, all the mutant proteins had compromised activity suggesting the critical requirement of cysteine in mitigating intracellular carbonyl levels (Figure 3G). Furthermore, we observed that exposure of cells to excess GO concomitantly enhanced the steady-state levels of Hsp31 paralogs to approximately three-fold (Figure 3—figure supplement 1D, E). These results indicate a direct role of yeast DJ-1 orthologs in modulating CML levels through regulating endogenous glyoxal.

Hsp31 alone specifically prevents the accretion of methylglyoxal-derived AGEs

MG is the most reactive dicarbonyl with the highest potency for glycating vital macromolecules, causing organellar damage due to membrane permeability (Allaman et al., 2015). To overcome MG toxicity, the glyoxalase system (GLO1 and GLO2) inevitably exploits the GSH pool for detoxification and thus alters the cellular redox balance (de Bari et al., 2020). On the other hand, DJ-1 members are functionally independent and do not utilize GSH as a cofactor for detoxification. To determine the methylglyoxalase activity of Hsp31 paralogs in vitro, we purified proteins recombinantly and subjected them to activity analysis. Strikingly, Hsp31 alone exhibited robust methyglyoxalase activity compared to other paralogs (Figure 4A). This further confirms the specific enrichment of MAGE-modified macromolecules found earlier in Δ31 strain (Figures 1D, 2G and I). On the contrary, Hsp32, Hsp33, and Hsp34 demonstrated significantly lower methyglyoxalase activity in agreement with the lack of MAGE modifications (Figures 1D, 2G and I).

Figure 4. Hsp31 is a potent scavenger of methylglyoxal.

Figure 4.

(A) In vitro methylglyoxalase activity. Purified Hsp31 members 5 µg each were incubated with 0.5 mM MG, and the absorbance at 530 nm was monitored. (B) Spot assay. Respective strains grown till the mid-log phase were harvested and treated with 10 mM MG for 5 hr before spotting on SD Leu- plates. Images were captured at 36 hr. (C–E) Hsp31 reduces MG-derived AGE modifications. Individual strains were treated with 10 mM MG in the culture tubes for 12 hr, and the macromolecule glycation was analyzed using an anti-MAGE antibody. (F) C138 amino acid residue is critical for methylglyoxalase activity. 5 µg of Hsp31-WT and Hsp31C138A mutant were incubated with MG, and the activity was examined at 530 nm. BSA was used as negative control in enzymatic assay. Glycation levels represent the relative intensities of the dots and lanes compared with WT. One-way ANOVA with Dunnett’s multiple comparisons test was used to determine significance from three independent biological replicates, *, p≤0.05; **, p≤0.01; ***, p≤0.001; NS, not significant.

Figure 4—source data 1. Source data for Figure 4A contains densitometric values for graph.
Figure 4—source data 2. Source data for Figure 4C contains raw image of western blot and densitometric values for graph.
Figure 4—source data 3. Source data for Figure 4D contains raw image of western blot and densitometric values for graph.
Figure 4—source data 4. Source data for Figure 4E contains raw image of western blot and densitometric values for graph.
Figure 4—source data 5. Source data for Figure 4F densitometric values for graph.

Remarkably, the overexpression of Hsp31 in ΔQ strain facilitated improved resistance towards MG treatment than its paralogs due to its potent methyglyoxalase activity (Figure 4B). Further, examining the proteome glycation by α-MAGE also indicated that Hsp31 markedly reduced MG glycated proteins compared to its paralogs (Figure 4C). To further substantiate the implications of methylglyoxalase activity of Hsp31 paralogs, modification of nucleic acids from the respective strains were investigated. Due to high intrinsic methylglyoxalase activity, Hsp31 alone could scavenge MG-associated glycation of nuclear DNA and global RNA (Figure 4D and E). Besides, the role of a catalytic cysteine (C138) residue in methylglyoxalase activity was evaluated due to its pivotal role in abating GO toxicity. The mutation of C138 to alanine in Hsp31 completely abolished the enzymatic activity (Figure 4F), which further emphasizes the prominence of a conserved cysteine in the catalytic triad of DJ-1 superfamily members. Together, our data suggest that Hsp31 provides glycation defense against both MG and GO, unlike Hsp32, Hsp33, and Hsp34.

Hsp31 paralogs repair glyoxal glycated DNA and proteins, suppress genetic mutations, and combat genotoxic stress

Glycation of macromolecules in S. cerevisiae is a rapid and spontaneous event with specific targets allowing them to tune their physiological functions (Gomes et al., 2005). However, glycation is also an irreversible process that may erroneously alter biomolecule features without a dedicated restoration pathway. Emerging studies have reported hDJ-1 as deglycase (EC 3.5.1.124) that relieves advanced glycation adducts from MG and GO-modified nucleotides and proteins (Richarme et al., 2017; Richarme et al., 2015). This observation unraveled a gateway to regulating the glycation status of essential components within cells across species.

We utilized the modified protocols to test whether the yeast Hsp31 paralogs possess deglycase activity (Prasad et al., 2022; Richarme et al., 2017). Briefly, deoxyribonucleotide triphosphate (dNTPs) were pre-treated without or with GO to glycate the substrates completely. The glycation mixture was further diluted to 6-fold to suppress the effect of free GO on the activity of Hsp31 paralogs. Later, the glycated substrates were incubated for 3 hr with purified Hsp31 paralogs and BSA as a control to test deglycase activity (Experimental scheme; Figure 5A). The deglycase activity was ascertained by amplifying the S. cerevisiae sod1 gene generated by Phusion high fidelity DNA polymerase that incorporates repaired dNTPs during PCR reaction. Unlike GO and BSA controls, incubation with Hsp31 paralogs efficiently reverted the glycation adducts of dNTPs, noted by robust amplification of the PCR product (Figure 5B). As an additional substrate of DNA, the forward and reverse oligonucleotide primers of the sod1 gene were glycated in the presence or absence of GO. Besides dNTPs, yeast DJ-1 orthologs prominently deglycated the primers, allowing the reaction to yield an intense PCR product in contrast to GO and BSA controls (Figure 5C).

Figure 5. In vitro deglycation of DNA and proteins, and genotoxic sensitivity in the absence of yeast DJ-1 orthologs.

(A) Schematic representation of the experimental procedure followed for DNA and protein deglycation reactions. (B, C) Hsp31 paralogs deglycate DNA. 500 µM dNTPs (B) or 150 µM forward and reverse primers (C) were incubated without (UN) or with 2 mM GO for 2 hr, followed by 3 hr incubation with 5 µg Hsp31 paralogs. The samples were examined for deglycation through PCR. (D, E) Yeast DJ-1 members repair glycated proteins. 2 µg of purified protein hSod1 (D) or Lysozyme (E) were treated without (UN) or with 2 mM GO for 2 hr, and the reactions were further incubated for 3 hr with Hsp31 paralogs. Anti-CML antibody was used to determine glycation levels. BSA was used as a negative control in all experiments. 10 kb DNA ladder was used as a marker (M) for DNA gels, and the Ponceau S stain indicates the equal loading of protein samples. (F) Hsp31 paralogs attenuate genetic mutations. Individual genes were PCR amplified, and Sanger sequenced from the isolated genome of strains treated with 15 mM GO. The number of genetic mutations was calculated and plotted on GraphPad prism 5.0 (n=2). (G) Growth phenotypic analysis. Cells grown until the mid-log phase were spotted on plates containing 0.01% MMS or 15 mM GO or 0.01% MMS and 15 mM GO. The plates were incubated at 30 °C and imaged at 36 hr. (H) Western analysis of RNR3 levels. WT and ΔQ grown till the mid-log phase were supplemented with 0.01% MMS, and 15 mM GO in the culture media and further incubated for 3 hr. Subsequently, RNR3 levels were probed using an anti-HA antibody. (I) RAD52 foci formation. Cells were grown until the mid-exponential phase and were treated without (-) or with 0.03% MMS and 15 mM GO for 1 hr. Subsequently, cells were imaged using a confocal microscope (Olympus FV3000). Representative images have a 10 µm scale. All the experiments were performed in three independent biological replicates.

Figure 5—source data 1. Source data for Figure 5B contains raw image of agarose gel.
Figure 5—source data 2. Source data for Figure 5C contains raw image of agarose gel.
Figure 5—source data 3. Source data for Figure 5D contains raw image of western blot.
Figure 5—source data 4. Source data for Figure 5E contains raw image of western blot.
Figure 5—source data 5. Source data for Figure 5H contains raw image of western blot.
Figure 5—source data 6. Source data for Figure 5F contains multiple sequence alignment highlighting the mutations.

Figure 5.

Figure 5—figure supplement 1. GO-associated macromolecular deglycation, mutation frequency profile, and genotoxic damage.

Figure 5—figure supplement 1.

(A, B) Deglycation of DNA by C138A mutants of Hsp31 paralogs. dNTPs (500 µM) and DNA oligonucleotides (150 µM) were incubated for 2 hr in the absence and presence of 2 mM GO, followed by deglycation with Hsp31 paralogs and C138A mutants for 3 hr. (C, D) C138 amino acid residue is crucial for protein deglycase activity. 2 µg glycated hSod1 and Lysozyme were individually supplemented with 5 µg of Hsp31 paralogs (WT), or mutant paralogs (C138A) and subjected to western analysis to determine the glycation status (E) Respective genes were PCR amplified from cells treated with 15 mM GO for 16 hr and Sanger sequenced. The number of genetic mutations from various genes is represented here. (F) Phenotypic analysis under DNA damaging agents. The cells harvested from the mid-log phase were spotted on plates containing 0.01% MMS or 150 mM HU. Plates were incubated at 30 °C and imaged at 36 hr. (G) Quantitation of RAD52 foci formation. Foci of individual strains were quantitated from three independent biological replicates, statically analysed through paired t-test and plotted on Prism GraphPad 5.0.
Figure 5—figure supplement 1—source data 1. Source data for Figure 5—figure supplement 1A contains raw image of agarose gel.
Figure 5—figure supplement 1—source data 2. Source data for Figure 5—figure supplement 1B contains raw image of agarose gel.
Figure 5—figure supplement 1—source data 3. Source data for Figure 5—figure supplement 1C contains raw image of western blot.
Figure 5—figure supplement 1—source data 4. Source data for Figure 5—figure supplement 1D contains raw image of western blot.
Figure 5—figure supplement 1—source data 5. Source data for Figure 5—figure supplement 1G contains densitometric values of graph.

The chronic glycation of proteins induces multifactorial changes that potentially trigger aggregation, cross-linking, and cytotoxicity. Therefore, it is critical to study whether Hsp31 paralogs confer the glycation repair of proteins. To determine the deglycase property, human Sod1, and Lysozyme were pre-treated without or with GO separately for 2 hr to form glycation adducts. The reaction mixture was diluted 6-fold and incubated for 3 hr with purified Hsp31 members or BSA (negative control) (Experimental scheme; Figure 5A). The samples were separated on SDS-PAGE and subjected to immunodetection by anti-CML antibody to confirm the degree of glycation. All the Hsp31 members exhibited robust deglycase activity, as the paralogs extensively reverted the glycation damage of proteins, unlike GO and BSA controls (Figure 5D and E). On the other hand, the active site mutation (C138A) in paralogs was tested to verify deglycase enzyme activity further. The active site mutants failed to relieve the glycation adducts on DNA and proteins, thus establishing the specificity of the deglycase action of Hsp31 paralogs (Figure 5—figure supplement 1A–D).

As GO is known to induce random mutations that severely impair genome integrity, we scored the glycation-induced conversions at the DNA level to investigate the impact of glyoxalase and deglycase activity of Hsp31 paralogs on genome protection. Strains lacking Hsp31 paralogs were subjected to GO treatment, and mutation frequency was determined by amplifying specific genes such as mitochondrial-encoded (cox2) and nuclear-encoded (sod1 and rad14), which have vital in vivo functions. Due to the loss of Hsp31 paralogs, the ΔQ strain exhibited enhanced mutation frequency as determined by cox2, sod1, and rad14 gene sequencing (Figure 5F). However, due to robust intrinsic glyoxalase and deglycase activity associated with the paralogs, the overexpression of Hsp31, Hsp32, Hsp33, and Hsp34 significantly attenuated the mutation frequency of all the genes tested, further highlighting their physiological role in the maintenance of genome integrity under the GO toxicity (Figure 5F and Figure 5—figure supplement 1E).

To further establish their role in offering genome integrity, WT and ΔQ strains were exposed to well-known genotoxic agents such as methyl methanesulfonate (MMS) and hydroxyurea (HU). The ΔQ strain showed severe growth sensitivity towards MMS and HU treatment compared to WT (Figure 5—figure supplement 1F). Furthermore, treatment with GO and genotoxins combined showed a synergistic increment in the growth sensitivity of ΔQ compared to their individual treatments (Figure 5G). These genotoxins induce DNA lesions and strand breaks, which could be monitored by the expression of DNA damage response genes such as RNR3 (subunit of RiboNucleotide Reductase) that specifically upregulates during genotoxic stress (Fu et al., 2008). Intriguingly, ΔQ exhibited a notable increase in the expression of RNR3 compared to WT cells treated with MMS and GO (Figure 5H). Besides RNR3, multiple DNA repair proteins, including RAD52, assemble at the strand break regions. Hence, the formation of RAD52-GFP foci indicates the extent of DNA damage in cells (Conde and San-Segundo, 2008). Intriguingly, ΔQ strain displayed a threefold increment in RAD 52 foci formation compared to WT upon treatment with MMS and GO (Figure 5I and Figure 5—figure supplement 1G). In summary, our findings indicate that the Hsp31 members collectively attenuate the genotoxic damage and participate in an antiglycation pathway that globally detects and restores the GO-modified biomolecules.

Hsp31 alone explicitly reverts methylglyoxal glycated macromolecules and attenuates mutation frequency

Balancing the physiological amount of dicarbonyls is a major biological challenge as they have a short half-life and quickly react with nearby biomolecules. Besides glyoxalase-I and II systems, very few enzymes have been identified to detoxifying MG (Vander Jagt and Hunsaker, 2003). About 90–99% of cellular MG is bound to macromolecules, which may be reversible by the action of deglycases (Allaman et al., 2015). We utilized a modified protocol to test whether the paralogs attenuate MG-mediated modification of DNA and proteins (Richarme et al., 2017). As illustrated in schematic Figure 6A, the dNTPs or DNA oligonucleotide primers substrates were incubated in the absence or presence of MG, followed by sixfold dilution of the reaction mixture to minimize the effects of free MG on the enzymatic activity of Hsp31 paralogs. Later, purified DJ-1 members were added, and deglycase activity was ascertained by PCR of the sod1 gene using Phusion high-fidelity DNA polymerase. In line with our findings, Hsp31 alone suppressed the MG-mediated glycation through its deglycase activity, yielding robust amplification of PCR product (Figure 6B and C).

Figure 6. Hsp31 repairs MG-derived AGE modifications on DNA and proteins.

(A) Schematic representation of the experimental procedure used for DNA and protein deglycation reactions. (B, C) DNA deglycation by Hsp31. 500 µM dNTPs (B) or 150 µM forward and reverse primers (C) were incubated without (UN) or with 2 mM MG for 2 hr. Subsequently, 5 µg Hsp31 paralogs were added and incubated for 3 hr. The samples were subjected for PCR analysis. (D, E) Hsp31 reverts MG modification on proteins. hSod1 (D) and Lysozyme (E) were glycated for 2 hr with 2 mM MG and incubated with Hsp31 paralogs. The glycation status was determined through western analysis against anti-MAGE antibody. 10 kb DNA ladder was used as a marker (M) for DNA gels, and the Ponceau S stain indicates the equal loading of protein samples. BSA was used as a negative control in all experiments. The experiments were performed in three independent biological replicates. (F) The dual role of Hsp31 reduces MG-induced DNA mutations. Respective genes were PCR amplified, and Sanger sequenced from strains treated with 10 mM MG. The number of genetic mutations was plotted on GraphPad prism 5.0 (n=2).

Figure 6—source data 1. Source data for Figure 6B contains raw image of agarose gel.
Figure 6—source data 2. Source data for Figure 6C contains raw image of agarose gel.
Figure 6—source data 3. Source data for Figure 6D contains raw image of western blot.
Figure 6—source data 4. Source data for Figure 6E contains raw image of western blot.
Figure 6—source data 5. Source data for Figure 6F contains multiple sequence alignment highlighting the mutations.

Figure 6.

Figure 6—figure supplement 1. Hsp31C138A fails to repair glycated DNA and proteins.

Figure 6—figure supplement 1.

(A–D) Hsp31C138A mutant lacks deglycase activity. Macromolecules were treated with 2 mM MG for 2 hr and incubated with Hsp31-WT and Hsp31C138A mutant (2 µg each). The glycation status was determined through PCR and western analysis. (E) Individual genes, as indicated, were PCR amplified from various strains incubated with 10 mM MG for 16 hr and Sanger sequenced. The number of genetic mutations was determined and represented here.
Figure 6—figure supplement 1—source data 1. Source data for Figure 6—figure supplement 1A contains raw image of agarose gel.
Figure 6—figure supplement 1—source data 2. Source data for Figure 6—figure supplement 1B contains raw image of agarose gel.
Figure 6—figure supplement 1—source data 3. Source data for Figure 6—figure supplement 1C contains raw image of western blot.
Figure 6—figure supplement 1—source data 4. Source data for Figure 6—figure supplement 1D contains raw image of western blot.

To delineate the MG-associated protein deglycation, hSod1, and Lysozyme were treated without or with MG and probed with α-MAGE antibody. In the presence of Hsp31, the glycation adducts on the proteins was significantly reverted (Figure 6D and E). On the other hand, the Hsp32, Hsp33, and Hsp34 failed to revert the glycation of proteins in vitro, similar to DNA substrates (Figure 6D and E). The Hsp31 active site mutant (C138A) also failed to repress the MG adducts on DNA and proteins, underlining its significance in the catalytic reaction (Figure 6—figure supplement 1A–D). We also determined if the dual role of Hsp31 could provide genome integrity by scoring the MG-induced DNA mutations. Strikingly, the ΔQ strain displayed an augmented mutation rate, which was notably abated by the expression of Hsp31 during MG toxicity, confirmed by amplification and sequencing of selected yeast-specific genes (Figure 6F and Figure 6—figure supplement 1E). Thus, our data establish a critical function of Hsp31 in suppressing the MG-mediated aberrant glycation of macromolecules in S. cerevisiae.

Dicarbonyl stress induces translocation of Hsp31 paralogs into mitochondria for organelle protection

DJ-1 superfamily members display dynamic subcellular localization into various organelles, such as the nucleus and mitochondria, during the stress response (Bankapalli et al., 2015; Conde and San-Segundo, 2008; Fu et al., 2008). However, the significance of the redistribution is still unclear. Therefore, we investigated whether Hsp31 paralogs localize to mitochondria during GO toxicity. To determine, the Hsp31 paralogs were genomically fused with GFP, and the mitochondria were decorated by targeting mCherry tagged with mitochondrial targeting sequence (MTS). Under normal physiological conditions, the paralogs were predominantly localized in the cytosol (Figure 7A–D, -GO untreated panels). Strikingly, upon treatment of cells with GO, all the Hsp31 paralogs translocate into mitochondria, as highlighted by the merged images of GFP and mCherry (Figure 7A–D,+GO stress panels).

Figure 7. Dicarbonyl-induced translocation of yeast DJ-1 orthologs into mitochondria.

(A–E) Mitochondrial translocation of Hsp31 paralogs. WT strain expressing genomic GFP tagged Hsp31 paralogs, and MTS-mCherry (decorates mitochondria) plasmid were treated with either buffer (-GO/-MG) or 15 mM GO (+GO) or 10 mM MG (+MG) for 3 hr. Consequently, images were captured in a confocal microscope (Olympus FV3000) and represented with 10 µm scale. (F–G) Mitochondrial protein and DNA glycation levels. WT and ΔQ overexpressing Hsp31 class of proteins were treated with 15 mM GO stress, followed by isolation of mitochondria and western analysis to determine glyoxal modifications using anti-CML antibody. The intensity of each lane and dot was quantitated densitometrically and plotted in the graph. One-way ANOVA with Dunnett’s multiple comparisons test was used to determine significance from three independent biological replicates, *, p≤0.05; **, p≤0.01; ***, p≤0.001; NS, not significant.

Figure 7—source data 1. Source data for Figure 7F contains raw image of western blot and densitometric values for graph.
Figure 7—source data 2. Source data for Figure 7G contains raw image of western blot and densitometric values for graph.

Figure 7.

Figure 7—figure supplement 1. Western and microscopic analysis of mitochondrial translocated Hsp31 paralogs.

Figure 7—figure supplement 1.

(A) Hsp31 paralogs genomically tagged with HA were treated with GO at log phase, and their levels were probed from fractionated mitochondria. For fold change, the band intensities were quantified and normalized with no treatment (-GO). The purity is indicated by the mitochondrial and cytosol control proteins, Tim23 and Ydj-1, respectively. (B) Probing mitochondrial translocated Hsp31. Mitochondria were isolated from MG-treated cells expressing Hsp31-HA. and subjected to immunoblotting to determine the levels. The band intensities from respective lanes were quantified and normalized with –MG. (C–E) MG does not affect the localization of Hsp32, Hsp33, and Hsp34. Cells containing genomic GFP-tagged Hsp31 paralogs and MTS-mCherry were incubated without (-MG) or with MG (+MG) and visualized under the microscope. (F) Purity of isolated mitochondria used in the study (Figure 7F, G) were analyzed for quality by probing with mitochondrial control, Tim23, and cytosol control Ydj-1 proteins. Paired t-test was used to determine significance of three independent biological replicates, *, p≤0.05; **, p≤0.01; ***, p≤0.001; NS, not significant.
Figure 7—figure supplement 1—source data 1. Source data for Figure 7—figure supplement 1A contains raw image of western blot and densitometric values for graph.
Figure 7—figure supplement 1—source data 2. Source data for Figure 7—figure supplement 1B contains raw image of western blot and densitometric values for graph.
Figure 7—figure supplement 1—source data 3. Source data for Figure 7—figure supplement 1F contains raw image of western blot.

To further support the microscopic findings, western analysis was performed to quantitatively measure the mitochondrial localization of Hsp31 paralogs from fractionated mitochondria of GO-treated and untreated cells. A ~2.5-fold level increase in the localization of Hsp31 paralogs into mitochondria was observed under GO toxicity (Figure 7—figure supplement 1A). As Hsp31 regulates MG-induced glycation of macromolecules, we determined its redistribution in response to MG stress. The microscopic visualization suggests that Hsp31 upon MG toxicity localizes into mitochondria (Figure 7E), which was further quantified from probing isolated mitochondria treated with MG stress. The immunoblots indicate a 2-3 fold enrichment of Hsp31 in mitochondria upon exposure to MG (Figure 7—figure supplement 1B). In contrast, Hsp32, Hsp33, and Hsp34 do not display mitochondrial redistribution under MG toxicity (Figure 7—figure supplement 1C–E), further emphasizing that Hsp31 and not its paralogs respond and mitigate broader stress conditions. Tim23 and Ydj-1 were probed for mitochondrial and cytosol control proteins, respectively (Figure 7—figure supplement 1F).

To understand the relevance of GO-dependent mitochondrial translocation of Hsp31 paralogs, mitochondria were isolated from cells supplemented with GO to analyze the altered glycation of mitochondrial macromolecules. Intriguingly, a significant portion of the mitochondrial proteome and DNA was glycated in ΔQ strain, while in the presence of Hsp31 paralogs, the glycation levels were substantially suppressed (Figure 7F and G). Since the Hsp31 paralogs govern the glycation of mitochondrial macromolecules, we studied mitochondrial health by determining the viability of deletion strains of yeast DJ-1 members on a non-fermentable carbon source (glycerol). Although we observe no growth difference in dextrose media, the collective absence of Hsp31 paralogs in ΔT and ΔQ induced sensitivity to glycerol media (Figure 8—figure supplement 1A). These results suggest that the disruption of yeast DJ-1 members compromises mitochondrial health.

Therefore, we further explored mitochondrial maintenance by Hsp31 paralogs by investigating various health parameters of the organelle. The mitochondrial morphology indicates the dynamic balance of the fusion-fission network, which could be affected by altered mitochondrial health. Under physiological conditions, ΔQ displayed a highly reticular mitochondrial network than WT, possibly due to elevated expression of Mgm1 and Fzo1 as reported by Bankapalli et al., 2020 in Δ31Δ34 (Figure 8A -GO panel). However, under glycation stress, WT showed fragmented morphology of mitochondria as compared to no stress (Figure 8A +GO panel). Strikingly, despite the increase in the reticular network, we observed higher fragmentation of mitochondria in ΔQ than WT upon glycation toxicity (Figure 8A +GO panel). As the glycation affected the mitochondrial morphology, we examined the impact on total and functional mitochondrial content through flow cytometric analysis using NAO and TMRE dyes, respectively. In the absence of GO stress, ΔQ showed an increase in overall mitochondrial content than WT, possibly due to hyperfusion of mitochondria (Figure 8B). Although the mass of mitochondria remained almost similar in WT, an increase in total mitochondrial content was found in ΔQ upon GO stress (Figure 8B). Next, functional mitochondrial mass was determined through TMRE dye, we observed comparable functional mitochondria in WT treated and untreated, while a significant loss of functional mitochondria was noted in ΔQ under glycation toxicity (Figure 8C). To score the glycation-induced damage on mitochondrial health, ATP levels were estimated from isolated mitochondria. Intriguingly, the glycation stress led to a substantial loss of mitochondrial ATP levels by ~40% in ΔQ compared to WT (Figure 8D). These results infer that glycation stress induces extensive mitochondrial damage and impaired clearances of dysfunctional mitochondria in the absence of Hsp31 paralogs.

Figure 8. Loss of yeast DJ-1 members induces mitochondrial dysfunction.

(A) Visualization of mitochondrial morphology. WT and ∆Q strains expressing MTS-mCherry (decorates mitochondria) were either treated with buffer (-GO) or 15 mM GO (+GO), followed by imaging. (B, C) FACS analysis to estimate total and functional mitochondrial mass. Respective strains were grown till the early log phase, followed by incubation with GO. Later, the cells were stained with Nonyl Acridine Orange (NAO) for total mass and TetraMethylRhodamine ethyl ester (TMRE) for determining functional mass. (D) Measurement of ATP levels. Selected strains were exposed to GO treatment at the mid-log phase. Consequently, the mitochondria were isolated, and the ATP levels were estimated through a fluorescence assay. (E) mtDNA staining by SYTO18. Following the treatment with GO, WT, and ∆Q were stained with SYTO18 dye. The microscopic analysis was performed in a confocal microscope (Olympus FV3000), with10 µm scale in images. All experiments were performed in three independent biological replicates and analysed through paired t-test to determine significance, *, p≤0.05; **, p≤0.01; ***, p≤0.001; NS, not significant.

Figure 8—source data 1. Source data for Figure 8B contains densitometric values for graph.
Figure 8—source data 2. Source data for Figure 8C contains densitometric values for graph.
Figure 8—source data 3. Source data for Figure 8D contains densitometric values for graph.

Figure 8.

Figure 8—figure supplement 1. Phenotypic analysis of Hsp31 deletion strains in non-fermentable carbon source.

Figure 8—figure supplement 1.

(A) Selected strains were grown till the early log phase and spotted on media plates containing YP dextrose (2%) or YP glycerol (2%). Plates were incubated at 30 °C, and images were acquired at 36 hr.

As mtDNA is prone to glycation in the absence of yeast DJ-1 members (Figure 7G), we examined the integrity of mtDNA by staining with mtDNA-specific SYTO18 stain (Ingavale et al., 2008; Matta et al., 2017). Incubation of WT with GO led to a reduction in SYTO18 staining with coalescent nucleoid morphology compared to untreated cells (Figure 8E, left panel). On the other hand, the lack of Hsp31 paralogs led to a significant reduction in SYTO18 staining with punctate nucleoid under GO stress compared to untreated cells (Figure 8E, right panel), suggesting their importance in maintaining mtDNA quantity and quality. In conclusion, the detoxification of carbonyls and macromolecular repair by yeast DJ-1 members is critical for preserving the global integrity of healthy mitochondria.

Discussion

Glyoxalase defence mechanism of the Hsp31 class of proteins is more robust than GLO-1 system

The present study highlights robust glyoxalase activities of yeast Hsp31 mini-family proteins essential to combat aberrant intracellular levels of RCS. Our in vitro experiments firmly establish the specificity of Hsp31 paralogs towards GO substrates, while Hsp31 alone detoxifies both MG and GO. Since Hsp32 and Hsp34 are structurally uncharacterized, we considered overlapping structural features with Hsp33 for comparative analysis due to its solved crystal structure and close sequence similarity. Strikingly, Hsp32, Hsp33, and Hsp34 possess a similar active site offering different substrate specificity than Hsp31. Such preferential scavenging of carbonyls is also observed in bacteria and plant DJ-1 members where YajL, ElbB, AtDJ-1A, and AtDJ-1B are GO specific, and some orthologs detoxify both substrates (Kwon et al., 2013; Lee et al., 2016). Although MG and GO are detoxified through distinct pathways, certain NADPH-dependent enzymes like aldehyde dehydrogenase and aldose reductase scavenge both the carbonyls, with their activities stringently governed by cellular redox status (Vander Jagt and Hunsaker, 2003).

In contrast to MG catabolism, the primary antioxidant GSH inefficiently reacts with GO making it a poor substrate for the GLO1 glyoxalase system (Yang et al., 2011). Hence, S. cerevisiae has bonafide multiple DJ-1 orthologs, and their steady-state levels are rapidly upregulated in response to GO allowing efficient carbonyl homeostasis. Our results highlight that the deletion of individual paralogs shows moderate sensitivity for GO. However, the collective loss of yeast DJ-1 orthologs (ΔQ) renders severe growth deficiency more than Δglo1. At the same time, their absence promotes severe accumulation of toxic carbonyls leading to a higher fold macromolecular glycation than Δglo1. Besides scavenging RCS, Hsp31 is also reported to provide partial tolerance toward acetic acid stress, also a deleterious glycolytic intermediate (Ansari et al., 2018; Natkańska et al., 2017). These findings suggest that Hsp31 members are paramount in regulating a broad group of toxic metabolites compared to the GLO system (1 and 2), which is restricted to specific carbonyls. Moreover, under oxidative damage, the activity of the GLO system (1 and 2) is impaired due to extensive utilization of the limiting pool of GSH. In contrast, the GSH-independent Hsp31 paralogs aid in restoring redox balance and simultaneously provide robust RCS homeostasis, hence, indispensable for cellular viability under carbonyl stress.

Global surveillance of nucleic acid glycation by yeast DJ-1 orthologs regulates the genome integrity

Despite several harmful effects, the physiological amounts of glycation are critical for post-translation modification, required for signaling in numerous pathways (Akhand et al., 2001; Rodrigues et al., 2020). Both MG and GO are known to glycate histone proteins, hitherto, 28 site-specific modifications on histones have been identified as targets of MG (Ansari et al., 2018; Galligan et al., 2018; Ray et al., 2022). Such non-enzymatic covalent epigenetic modifications regulate stress adaptations by altering chromatin architecture and gene expression. We highlight that Hsp31 paralogs are essential repair enzymes that regulate the degree of nucleic acid glycation by indirectly detoxifying the carbonyls or directly removing adducts by deglycation. This corroborates well with the idea that Hsp31 paralogs preserve genome integrity by lowering deleterious mutations as a counter-response (Figure 9). Also, the absence of paralogs elicits enhanced sensitivity to DNA damage stress when exposed to multiple genotoxins, as indicated by enriched expression of RNR3 and RAD52 foci formation, suggesting their strong association with genome maintenance. At the molecular level, the antiglycation property of the paralogs could also prevent the replication stress by replenishing repaired dNTP pool. Hsp31 members are widely recognized for metabolic and transcriptional reprogramming during the diauxic shift as they extensively tune the expression of necessary proteins for rapid acclimatization (Miller-Fleming et al., 2014). These observations may point to a unique regulatory mechanism by Hsp31 class of proteins similar to hDJ-1 in governing the carbonyl biology of chromatin landscape (Zheng et al., 2019).

Figure 9. Model depicting the role of yeast DJ-1 orthologs in the maintenance and protection against carbonyls.

Figure 9.

Various metabolic pathways generate MG and GO that spontaneously glycate cytosol and organellar macromolecules (1). Hsp31 paralogs scavenge excess endogenous RCS and regulate their levels (2). The dual role of paralogs provides nucleic acid protection by efficiently detoxifing the carbonyls and reversing of damaged molecules (3). Deglycation of proteins preserves the functional integrity of proteins (4). Dicarbonyl stress-induced translocation of Hsp31 paralogs into mitochondria confers enhanced organellar protection by attenuating damage to mitochondrial biomolecules (5). Created with BioRender.

Besides DNA, we found enriched glycation of RNA in ΔQ due to detrimental levels of MG and GO, accompanied by the disrupted mRNA translation at the global scale, possibly through compromised binding or stalling of ribosomes. Notably, yeast DJ-1 members extensively reverted the AGE modifications on RNA, suggesting their comprehensive role in translation regulation. The enhanced spectrum of mutations observed in various essential genes of ΔQ is a crucial indicator of a dedicated glycation repair pathway in S. cerevisiae (Figure 9). Interestingly, a recent report on Arabidopsis thaliana identified a novel glycation repair pathway similar to S. cerevisiae, involving AtDJ-1D in the repair of DNA and proteins (Prasad et al., 2022). Supporting the previous studies (Galligan et al., 2018; Nair et al., 2018; Richarme et al., 2017), we report yeast DJ-1 orthologs as a novel class of deglycases that repair RCS-mediated glycation of nucleic acids.

Hsp31 paralogs regulate the proteome glycation homeostasis

Proteins are the most abundant biomolecules with considerably longer half-lives, making them highly vulnerable to multiple non-enzymatic covalent modifications. Under physiological conditions, glycation on arginine, lysine, and cysteine modulates the functional diversity of various proteins (Sun et al., 2019). We show that the absence of Hsp31 paralogs triggers severe glycation of the proteome, which may contribute to protein aggregation, misfolding, and cross-linking. Furthermore, under these circumstances, the conventional proteasomal degradation pathway fails to provide quality turnover resulting in AGE accumulation (Raupbach et al., 2020). As a compensatory response mechanism, amino acid biosynthesis and protein translation were upregulated in the single deletions of Hsp31 mini-family proteins (Miller-Fleming et al., 2014). This primarily indicates the biogenesis of functional proteins to promote cell survival during glycation stress. Therefore, scavenging excess endogenous RCS by the Hsp31 paralogs is imperative to evade persistent glycation and maintain balanced proteostasis. Besides, their robust deglycase activity repairs severely glycated proteins from different cellular compartments, including mitochondria. This enables cells to efficiently reutilize the cellular proteome pool (Figure 9). In contrast, human DJ-1 exhibited weaker methylglyoxalase and deglycase activity than yeast and plant counterparts (Mazza et al., 2022).

Due to its chemical properties and redox-sensing ability, the catalytic cysteine in DJ-1 superfamily proteins holds critical importance during multi-stress responses (Wilson, 2011). In agreement with hDJ-1, C138A mutants of Hsp31 paralogs failed to repair macromolecules and detoxify RCS, suggesting a common multipurpose catalytic site.

Yeast DJ-1 orthologs provide mitochondrial protection during carbonyl stress

MG and GO toxicity is one of the leading factors contributing to mitochondrial dysfunction in most neurodegenerative diseases (Wang et al., 2019). Mechanistically, they disrupt the mitochondrial morphology and electron transport chain and elevate ROS levels (Videira and Castro-Caldas, 2018). Although DJ-1 superfamily proteins display dynamic subcellular localization during the stress response (Junn et al., 2009; Miller et al., 2003; Nair et al., 2018), their physiological relevance in mitochondrial protection is not well-studied. In a previous report, we showed the maintenance of mitochondrial morphology by regulating the fusion-fission network by Hsp31 and Hsp34 (Bankapalli et al., 2020). Here, we provide evidence of mitochondrial maintenance by yeast DJ-1 orthologs, effectively through global regulation of glycation stress and attenuation of glycation damage on mitochondrial macromolecules. Interestingly, Hsp31 members redistribute into mitochondria in response to carbonyl toxicity that may substantially lower the glycation of mitochondrial proteome and DNA, contributing to enhanced mitochondrial survival. Moreover, the mitochondrial translocation of the paralogs could elevate the glycolate synthesis from glyoxal, a critical antioxidant that maintains mitochondrial membrane potential during stress conditions and re-establishes redox balance by producing GSH (Diez et al., 2021; Toyoda et al., 2014). Hence, under carbonyl stress, their absence leads to the accumulation of fragmented and dysfunctional mitochondria, significantly attenuating the availability of the ATP pool and contributing to detrimental mitochondrial health. The dysfunctional mitochondria are accompanied by poor maintenance of mitochondrial DNA quality, which may further suppress the activity of mitochondrial DNA-encoded respiratory complexes leading to compromised ATP generation. These pathogenic alterations of mitochondria are central to neurodegeneration and the rapid progression of PD.

Besides impaired carbonyl homeostasis, a major contributor to PD progression is α-synuclein toxicity (Spillantini et al., 1997). Its physiological role involves interaction with mitochondrial complex I and ATP synthase. However, MG glycated α-synuclein forms cytotoxic oligomers, which may induce mitophagy and mitochondrial fragmentation (Faustini et al., 2017; Vicente Miranda et al., 2017). Therefore, cells rely on DJ-1 member proteins that possess glyoxalase and deglycases to abrogate the toxic accumulation of glycated products. Our findings highlight a possible neuroprotective function of PD-associated hDJ-1 involving the repair of damaged macromolecules and mitochondrial quanlity control, promoting healthy maintenance of neuronal cells with intrinsically higher levels of RCS (Angeloni et al., 2014).

In summary, our findings significantly contribute to understanding the diversified response by Hsp31 paralogs in the field of carbonyl biology. Through the novel repair pathway identified in S. cerevisiae, the AGEs formation is efficiently suppressed, and mitochondrial performance is enhanced during chronic exposure to RCS. Although Hsp31 paralogs display stress-induced mitochondrial redistribution, their translocation pathway is poorly studied. Therefore, mechanistic insights into the translocation process and their sub-compartment distribution would reveal critical mitochondrial-associated functions of Hsp31 paralogs. Also, further exploration of genotoxic damage induced in the absence of hsp31 paralogs may suggest how hDJ-1 encounters PD-linked chromatin aberrations.

Materials and methods

Strains and plasmid constructions

The yeast strains used in this study are mentioned in Supplementary file 1. The details of the primers and plasmids utilized in this study are described in Supplementary file 1. Knockouts of Hsp31 paralogs were generated through homologous recombination in haploid yeast strain BY4741 (MATα his3Δ1 leu2Δ0 met15Δ0 ura3Δ0). Deletion of hsp3232), hsp3333), and glo1glo1), was performed by transforming suitable cassettes generated by primers P1-P4, constituting the hphNT1 marker. Subsequently, the deletions were confirmed through PCR using primers P5-P8. The strains lacking hsp31 (Δ31) and hsp34 (Δ34) were previously generated in the lab. The double, triple (ΔT), and quadruple (ΔQ) deletion strains were generated by transforming DNA cassettes in Δ31Δ34. All the deletion strains were confirmed through PCR using primers P5-P8. RNR3 and Hsp31 paralogs expression was determined by genomically tagging at the C-terminus with heme agglutinin (HA) tag using primer P9-P11 and P12-P14, respectively, with hphNT1 cassette as described above. Primers P15-P18 were used to tag RAD52 with GFP at the carboxy terminus in WT and ΔQ.

For overexpression studies, Hsp31 paralogs containing C-terminus heme agglutinin (HA) tag were cloned into pRS415 vector with GPD (glyceraldehyde-6-phosphate dehydrogenase) promotor and transformed into ΔQ. For protein expression and purification, Hsp31 family proteins were cloned into pRSF-Duet and purified with a previously published protocol (Bankapalli et al., 2015).

Western blot analysis

Indicated respective strains grown till the mid-log phase (A600~0.6) were treated with 10 mM MG or 15 mM GO for 12 hr in the culture tubes. Later, the cell lysates were prepared by incubating with 10% Trichloro acetic acid solution at 4 °C. Following acetone washes, 1 X SDS dye (50 mM Tris-HCl, pH 6.8, 2% SDS, 0.1% bromophenol blue, 10% glycerol, and 100 mM b-mercaptoethanol) and acid-washed glass bead was added and vortexed thoroughly. Subsequently, the samples were heated at 92 °C, and 30 µg of the sample was loaded. The lysates were resolved on 12% SDS-PAGE and transferred to the PVDF membrane. The membrane was blocked with 5% BSA in phosphate-buffered saline (PBST-Tween 0.05%). Later, the membrane was incubated overnight with anti-CML or anti-MAGE antibody 1:1000 at 4 °C. Following three washes with PBST, the membrane was incubated with the secondary antibody (1:10,000) at room temperature. Subsequently, the membrane was washed with PBST and exposed to luminol solutions (BIO-RAD). Equal loading of samples was confirmed through ponceau S staining of the membrane.

To determine the expression levels of Hsp31 paralogs in response to GO treatment, the WT strain containing genomic HA tag on the C-terminus of Hsp31 members was incubated in the absence or presence of 15 mM GO for 12 hr. Subsequently, the cell lysates were resolved on 15% SDS-PAGE and probed with an anti-HA antibody. Similarly, WT and ΔQ were incubated without or with 0.01% MMS, and 15 mM GO for 3 hr to estimate the expression of RNR3. The fold change in all experiments was calculated by measuring the band intensities using Multi Gauge V3.0 software.

Nucleic acid glycation and DNA dot blot analysis

Yeast strains grown till the mid-exponential phase were treated with 10 mM MG or 15 mM GO in the culture tubes for 12 hr (Brown, 2001). Subsequently, genomic DNA was isolated using Wizard genomic DNA extraction kit (Promega, Cat No: A1120). For RNA isolation, cells were treated with 10 mM Tris pH 7.5, 1 mM EDTA, and 0.5% SDS (TES) buffer with hot acidic phenol for 1 hr at 65 °C. The resulting organic layer obtained after centrifugation was mixed with chloroform and centrifuged to acquire pure RNA. DNA and RNA were sheared through sonication and dotted (3 µg) on the nitrocellulose membrane (BIO-RAD, Cat No: 1620112). The membrane was baked at 80 °C for 2 hr and blocked-in phosphate-buffered saline (PBS-Tween 0.05%) with 5% BSA for 2 hr at room temperature. Consequently, the membrane was probed overnight with an anti-CML or anti-MAGE antibody. Following the washes, the membrane was incubated with a secondary anti-mouse antibody. The membrane was exposed to luminol solutions. The membrane was stained with methylene blue to confirm equal loading of the samples.

Polysome profiling

The experiment was performed using an established protocol (Shaffer and Rollins, 2020). Briefly, WT and ΔQ strains were grown till the mid-log phase and treated with 15 mM GO for 4 hr at 30 °C, and post-treatment cycloheximide was added to immobilize the ribosomes on mRNA. The cell lysates were prepared by adding lysis buffer (10 mM Tris pH 7.4, 100 mM NaCl, 30 mM MgCl2, 100 µg/ml cycloheximide, 10 U RiboLock, and 1 mM PMSF) to the pellet and vortexed with glass beads. The lysates were loaded on SW41 tubes containing a 10% to 50% sucrose density gradient, followed by ultra-centrifugation. Later, the fractions were analyzed using a polysome profiler (Piston gradient fractionator; BIOCOMP). The area under the curve of polysome and monosome was calculated using Origin 8.0, and the ratio was plotted in Prism GraphPad 5.0.

Phenotypic analysis and growth conditions

Individual yeast strains were grown till mid-log phase(A600~0.6) in YPD (yeast extract-1%, peptone-2%, and dextrose-2%) or synthetic dropout (SD) lacking leucine amino acid (0.67% yeast nitrogen base without amino acids, 0.072% Leu dropout supplement, and 2% dextrose). Consequently, cells were pelleted and serially diluted 10-fold until 10–5 dilution factor. Each dilution was spotted on the media plate without or with 15 mM GO. Parallelly, the cell pellet was treated with water or 10 mM MG for 6 hr, serially diluted, and spotted on media plates. The plates were incubated at 30 °C for 36 hr and imaged. Phenotype under DNA damaging agents was determined by spotting cells from the mid-exponential phase onto YPD media plates containing 0.01% MMS (methyl methanesulfonate) or 150 mM HU (hydroxyurea). Also, the cells were spotted on YPD media plates containing 15 mM GO or 0.01% MMS and plates with both genotoxins. Images of spot assay were taken at 36 hr. For growth assay on non-fermentable carbon source, mid-log phase cells were spotted on S.D. Glycerol (2%) media.

In vitro glyoxalase and methylglyoxalase activity

A previously established protocol was used to determine the activity (Bankapalli et al., 2015; Lee et al., 2016). To determine the enzyme activity, 5 µg of purified Hsp31 paralogs WT and C138A mutants were incubated with 0.5 mM GO or MG in HEPES KOH pH 7 buffer for 30 min at 30 °C. Later, the reaction was terminated using 0.1% DNPH (2,4-dinitrophenylhydrazone), followed by adding 10% NaOH and incubating at 42 °C for 10 min. The results were calorimetrically analyzed using Biospectrometer (Eppendorf), 570 nm for GO, and 530 nm for MG. The kinetic parameters were determined by incubating Hsp31 members with varying GO concentrations, and the readings were noted at different time points. The experiments were performed in three biological replicates and triplicates. Subsequently, the values were plotted on Prism GraphPad 5.0 to estimate the Km and Vmax.

In vitro deglycation assay of DNA and Proteins

The deglycation of DNA and protein was performed using previously published protocols with minor modifications (Richarme et al., 2017). For DNA deglycation experiments, 500 µM dNTPs or 150 µM forward and reverse primers of yeast sod1 (P19-P20) were incubated without or with GO/MG (2 mM) in HEPES KOH buffer pH 7 at 30 °C for 2 hr. Before supplementing the reactions with Hsp31 paralogs, the glycation mixtures were first diluted (6-fold) to minimize the free GO or MG levels. Post glycation reaction, 5 µg of purified Hsp31 paralogs and BSA were supplemented and incubated for 3 hr at 30 °C. The deglycase activity of Hsp31 paralogs was determined by subjecting the samples to a polymerase chain reaction (PCR) to amplify the sod1 gene in the presence of Phusion enzyme high fidelity DNA polymerase.

To measure the protein deglycation activity, 2 µg of purified human Sod1 and Lysozyme were treated without or in the presence of 2 mM GO/MG in HEPES KOH buffer pH 7 at 30 °C for 2 hr (Prasad et al., 2022). Subsequently, the samples were diluted 6-fold to minimize GO or MG residual levels. Post glycation of protein samples, the reaction mixture was supplemented with 5 µg of purified Hsp31 paralogs and incubated for 3 hr for deglycation. The deglycation status of proteins was determined by resolving the samples on 15% SDS-PAGE, followed by western analysis and immunodetected with anti-CML or anti-MAGE antibodies.

Genetic mutation and sequencing

Respective strains were grown till the mid-log phase and treated with 15 mM GO or 10 mM MG in the culture flasks for 24 hr at 30 °C. Total DNA was isolated as described above, and PCR amplified for sod1, rad14, and cox2 ORFs using primers P19-P24. Subsequently, the amplicons were sequenced by the Sangar method, and the raw reads were aligned with the WT sequences. The number of mutations was determined using the multiple-sequence alignment tool Clustal Omega and the data was plotted on GraphPad Prism 5.0.

Microscopic analysis

To analyse the formation of RAD52 GFP foci, WT and ΔQ cells were grown until the exponential phase and treated with 0.03% MMS and 15 mM GO for 1 hr. Subsequently, the A600=0.5 OD cells were harvested and washed with 1 X PBS before spreading over 2% agarose pads. The number of foci were quantified and plotted.

The localization of yeast DJ-1 members was performed by genomically tagging with GFP at the carboxy terminus using primers P12-P14. Consequently, the cells were transformed with a pRS415TEF vector expressing MTS-mCherry to decorate mitochondria (Bankapalli et al., 2015). The transformed strains grown until the mid-exponential phase were harvested (A600=0.5) and incubated with water or 15 mM GO for 2 hr. Parallelly, the cells were treated with water or 10 mM MG for 2 hr and harvested. The cell pellet was washed with 1 X PBS and processed for imaging. All the images were acquired in confocal microscopy (Olympus FV3000) with a 10 µm scale bar.

For mitochondrial DNA visualization, selected strains were grown till the mid-log phase and treated with 15 mM GO for 3 hr. Later, cells were harvested and stained with 10 μM SYTO 18 for 15 min at 30 °C, followed by visualization under confocal microscopy (Olympus FV3000). Images contain 10 µm scale bar.

Analysis of mitochondrial mass

WT and ∆Q were grown to the early log phase and treated without or with 15 mM GO for 3 hr. Later, the cells were stained with 10 µm Nonyl Acridine Orange (NAO) for total mitochondrial mass or 10 µm TetraMethylRhodamine ethyl ester (TMRE) for measuring functional mass. The cells were subsequently washed and examined under a cytoFLEX flow cytometer.

Measurement of mitochondrial ATP levels

A total of 30 µg of fractionated mitochondria from WT and ∆Q strains treated with GO were lysed and incubated with ATP detection solution from Mitochondrial ToxGlo Assay kit (Promega, Madison, USA). The luminescence was recorded using TECAN pro800.

Chemicals and antibodies

Chemicals used in the study are Glyoxal (Sigma,128465), Methylglyoxal (Sigma, M0252), Methyl Methanesulfonate (TCI, M0369), Hydroxyurea (Sigma, H8627), Lysozyme (Sigma, 4403), and nitrocellulose membrane (BIO-RAD,1620112). Antibodies used in the study are anti-CML (Carboxymethyl lysine; MAB3247 R&D Systems, Minneapolis, MN, USA), anti-MAGE (Argpyrimidine specific; ab243074 Abcam), anti-Tim23 (BD Bioscience), anti-HA antibody (GT4810, Sigma), secondary mouse (GE-bioscience).

Miscellaneous

Mitochondria were isolated from cells treated with 15 mM GO or 10 mM MG for 16 hr using a previously published protocol (Kumar et al., 2020). For mitochondrial DNA, fractionated mitochondria were lysed and subjected to alkaline lysis DNA purification (Sambrook and Russell, 2006).

Statistical analysis

Glycation intensities of DNA and proteins were measured through quantitation of complete dots or lanes, respectively, in Multi Gauge V3.0 software. The values were normalized with respect to WT in all experiments and plotted in GraphPad Prism 5.0 software. Error bars represent the standard deviation derived from three biological replicates. One-way ANOVA with Dunnett’s multiple comparisons test was used to determine significance analysis, comparing multiple columns against the WT or paired t-test for analysing single column. Asterisks used in the figures represent the following significance values: *, p≤0.05; **, p≤0.01; ***, p≤0.001; ****, p≤0.0001; NS, not significant.

Acknowledgements

We thank Prof. Umesh Varshney (Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India) for the utilization of the polysome profile machine and Prof. Elizabeth A Craig (University of Wisconsin-Madison, USA) for yeast vectors (pRS415TEF and pRS415GPD). We acknowledge the confocal microscope and flow cytometer facility (Department of Biochemistry, Indian Institute of Science, Bangalore, India). Prof. Patrick D’Silva acknowledges financial support from DST-SERB grant (CRG/2018/001988), Department of Biotechnology (DBT-IISC Partnership Program Phase-II, No. BT/PR27952/IN/22/212/2018), and DST-FIST Program-Phase III (No. SR/FST/LSII045/2016 G). Gautam Susarla and Priyanka Kataria acknowledge the fellowship from Indian Institute of Science-Bangalore, India. Amrita Kundu acknowledges the fellowship from the Department of Biotechnology-Research associate (DBT-RA), India.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Patrick D'Silva, Email: patrick@iisc.ac.in.

Agnieszka Chacinska, IMol Polish Academy of Sciences, Poland.

Detlef Weigel, Max Planck Institute for Biology Tübingen, Germany.

Funding Information

This paper was supported by the following grants:

  • Science and Engineering Research Board CRG/2018/001988 to Patrick D'Silva.

  • Department of Science and Technology, Ministry of Science and Technology, India SR/FST/LSII045/2016-G to Patrick D'Silva.

  • Department of Biotechnology, Ministry of Science and Technology, India BT/PR27952/IN/22/212/2018 to Patrick D'Silva.

Additional information

Competing interests

No competing interests declared.

Author contributions

Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing – review and editing.

Conceptualization, Data curation, Formal analysis, Visualization, Methodology, Writing – review and editing.

Data curation, Formal analysis, Validation, Methodology.

Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Project administration, Writing – review and editing.

Additional files

Supplementary file 1. List of strains, primers, and plasmids used in this study.
elife-88875-supp1.docx (30KB, docx)
MDAR checklist

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for all the Figures and Figure Supplements.

References

  1. Akhand AA, Hossain K, Mitsui H, Kato M, Miyata T, Inagi R, Du J, Takeda K, Kawamoto Y, Suzuki H, Kurokawa K, Nakashima I. Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells. Free Radical Biology & Medicine. 2001;31:20–30. doi: 10.1016/s0891-5849(01)00550-0. [DOI] [PubMed] [Google Scholar]
  2. Allaman I, Bélanger M, Magistretti PJ. Methylglyoxal, the dark side of glycolysis. Frontiers in Neuroscience. 2015;9:23. doi: 10.3389/fnins.2015.00023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Angeloni C, Zambonin L, Hrelia S. Role of methylglyoxal in Alzheimer’s disease. BioMed Research International. 2014;2014:238485. doi: 10.1155/2014/238485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ansari NA, Chaudhary DK, Dash D. Modification of histone by glyoxal: recognition of glycated histone containing advanced glycation adducts by serum antibodies of type 1 diabetes patients. Glycobiology. 2018;28:207–213. doi: 10.1093/glycob/cwy006. [DOI] [PubMed] [Google Scholar]
  5. Aslam K, Tsai CJ, Hazbun TR. The small heat shock protein Hsp31 cooperates with Hsp104 to modulate Sup35 prion aggregation. Prion. 2016;10:444–465. doi: 10.1080/19336896.2016.1234574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bandyopadhyay S, Cookson MR. Evolutionary and functional relationships within the DJ1 superfamily. BMC Evolutionary Biology. 2004;4:6. doi: 10.1186/1471-2148-4-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bankapalli K, Saladi S, Awadia SS, Goswami AV, Samaddar M, D’Silva P. Robust glyoxalase activity of Hsp31, a ThiJ/DJ-1/PfpI family member protein, is critical for oxidative stress resistance in Saccharomyces cerevisiae. The Journal of Biological Chemistry. 2015;290:26491–26507. doi: 10.1074/jbc.M115.673624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bankapalli K, Vishwanathan V, Susarla G, Sunayana N, Saladi S, Peethambaram D, D’Silva P. Redox-dependent regulation of mitochondrial dynamics by DJ-1 paralogs in Saccharomyces cerevisiae. Redox Biology. 2020;32:101451. doi: 10.1016/j.redox.2020.101451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MCJ, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003;299:256–259. doi: 10.1126/science.1077209. [DOI] [PubMed] [Google Scholar]
  10. Brown T. Dot and slot blotting of DNA. Current Protocols in Molecular Biology. 2001;Chapter 2:Unit2. doi: 10.1002/0471142727.mb0209bs21. [DOI] [PubMed] [Google Scholar]
  11. Chatterjee N, Walker GC. Mechanisms of DNA damage, repair, and mutagenesis. Environmental and Molecular Mutagenesis. 2017;58:235–263. doi: 10.1002/em.22087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Conde F, San-Segundo PA. Role of Dot1 in the response to alkylating DNA damage in Saccharomyces cerevisiae: regulation of DNA damage tolerance by the error-prone polymerases Polzeta/Rev1. Genetics. 2008;179:1197–1210. doi: 10.1534/genetics.108.089003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. de Bari L, Scirè A, Minnelli C, Cianfruglia L, Kalapos MP, Armeni T. Interplay among oxidative stress, methylglyoxal pathway and S-Glutathionylation. Antioxidants. 2020;10:19. doi: 10.3390/antiox10010019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Diez V, Traikov S, Schmeisser K, Adhikari AKD, Kurzchalia TV. Glycolate combats massive oxidative stress by restoring redox potential in Caenorhabditis elegans. Communications Biology. 2021;4:151. doi: 10.1038/s42003-021-01669-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Faustini G, Bono F, Valerio A, Pizzi M, Spano P, Bellucci A. Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson’s Disease? Genes. 2017;8:377. doi: 10.3390/genes8120377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fournet M, Bonté F, Desmoulière A. Glycation damage: A possible hub for major pathophysiological disorders and aging. Aging and Disease. 2018;9:880–900. doi: 10.14336/AD.2017.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fu Y, Pastushok L, Xiao W. DNA damage-induced gene expression in Saccharomyces cerevisiae. FEMS Microbiology Reviews. 2008;32:908–926. doi: 10.1111/j.1574-6976.2008.00126.x. [DOI] [PubMed] [Google Scholar]
  18. Galligan JJ, Wepy JA, Streeter MD, Kingsley PJ, Mitchener MM, Wauchope OR, Beavers WN, Rose KL, Wang T, Spiegel DA, Marnett LJ. Methylglyoxal-derived posttranslational arginine modifications are abundant histone marks. PNAS. 2018;115:9228–9233. doi: 10.1073/pnas.1802901115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gomes RA, Sousa Silva M, Vicente Miranda H, Ferreira AEN, Cordeiro CAA, Freire AP. Protein glycation in Saccharomyces cerevisiae. Argpyrimidine formation and methylglyoxal catabolism. The FEBS Journal. 2005;272:4521–4531. doi: 10.1111/j.1742-4658.2005.04872.x. [DOI] [PubMed] [Google Scholar]
  20. Goudarzi M, Kalantari H, Rezaei M. Glyoxal toxicity in isolated rat liver mitochondria. Human & Experimental Toxicology. 2018;37:532–539. doi: 10.1177/0960327117715900. [DOI] [PubMed] [Google Scholar]
  21. Ingavale SS, Chang YC, Lee H, McClelland CM, Leong ML, Kwon-Chung KJ. Importance of mitochondria in survival of Cryptococcus neoformans under low oxygen conditions and tolerance to cobalt chloride. PLOS Pathogens. 2008;4:e1000155. doi: 10.1371/journal.ppat.1000155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Inoue Y, Maeta K, Nomura W. Glyoxalase system in yeasts: structure, function, and physiology. Seminars in Cell & Developmental Biology. 2011;22:278–284. doi: 10.1016/j.semcdb.2011.02.002. [DOI] [PubMed] [Google Scholar]
  23. Junn E, Jang WH, Zhao X, Jeong BS, Mouradian MM. Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. Journal of Neuroscience Research. 2009;87:123–129. doi: 10.1002/jnr.21831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kumar A, Matta SK, D’Silva P. Conserved regions of budding yeast Tim22 have a role in structural organization of the carrier translocase. Journal of Cell Science. 2020;133:jcs244632. doi: 10.1242/jcs.244632. [DOI] [PubMed] [Google Scholar]
  25. Kwon K, Choi D, Hyun JK, Jung HS, Baek K, Park C. Novel glyoxalases from Arabidopsis thaliana. The FEBS Journal. 2013;280:3328–3339. doi: 10.1111/febs.12321. [DOI] [PubMed] [Google Scholar]
  26. Lange JN, Wood KD, Knight J, Assimos DG, Holmes RP. Glyoxal formation and its role in endogenous oxalate synthesis. Advances in Urology. 2012;2012:819202. doi: 10.1155/2012/819202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lee J, Song J, Kwon K, Jang S, Kim C, Baek K, Kim J, Park C. Human DJ-1 and its homologs are novel glyoxalases. Human Molecular Genetics. 2012;21:3215–3225. doi: 10.1093/hmg/dds155. [DOI] [PubMed] [Google Scholar]
  28. Lee C, Lee J, Lee J, Park C. Characterization of the Escherichia coli YajL, YhbO and ElbB glyoxalases. FEMS Microbiology Letters. 2016;363:fnv239. doi: 10.1093/femsle/fnv239. [DOI] [PubMed] [Google Scholar]
  29. Matta SK, Pareek G, Bankapalli K, Oblesha A, D’Silva P. Role of Tim17 transmembrane regions in regulating the architecture of presequence translocase and mitochondrial DNA stability. Molecular and Cellular Biology. 2017;37:e00491-16. doi: 10.1128/MCB.00491-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mazza MC, Shuck SC, Lin J, Moxley MA, Termini J, Cookson MR, Wilson MA. DJ-1 is not a deglycase and makes a modest contribution to cellular defense against methylglyoxal damage in neurons. Journal of Neurochemistry. 2022;162:245–261. doi: 10.1111/jnc.15656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Melvin P, Bankapalli K, D’Silva P, Shivaprasad PV. Methylglyoxal detoxification by a DJ-1 family protein provides dual abiotic and biotic stress tolerance in transgenic plants. Plant Molecular Biology. 2017;94:381–397. doi: 10.1007/s11103-017-0613-9. [DOI] [PubMed] [Google Scholar]
  32. Miller DW, Ahmad R, Hague S, Baptista MJ, Canet-Aviles R, McLendon C, Carter DM, Zhu P-P, Stadler J, Chandran J, Klinefelter GR, Blackstone C, Cookson MR. L166P mutant DJ-1, causative for recessive Parkinson’s disease, is degraded through the ubiquitin-proteasome system. The Journal of Biological Chemistry. 2003;278:36588–36595. doi: 10.1074/jbc.M304272200. [DOI] [PubMed] [Google Scholar]
  33. Miller-Fleming L, Antas P, Pais TF, Smalley JL, Giorgini F, Outeiro TF. Yeast DJ-1 superfamily members are required for diauxic-shift reprogramming and cell survival in stationary phase. PNAS. 2014;111:7012–7017. doi: 10.1073/pnas.1319221111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mitchell D, Ritchey LE, Park H, Babitzke P, Assmann SM, Bevilacqua PC. Glyoxals as in vivo RNA structural probes of guanine base-pairing. RNA. 2018;24:114–124. doi: 10.1261/rna.064014.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Murata-Kamiya N, Kamiya H, Kaji H, Kasai H. Glyoxal, a major product of DNA oxidation, induces mutations at G:C sites on a shuttle vector plasmid replicated in mammalian cells. Nucleic Acids Research. 1997;25:1897–1902. doi: 10.1093/nar/25.10.1897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Murata-Kamiya N, Kamiya H, Kaji H, Kasai H. Methylglyoxal induces G:C to C:G and G:C to T:A transversions in the supF gene on A shuttle vector plasmid replicated in mammalian cells. Mutation Research. 2000;468:173–182. doi: 10.1016/s1383-5718(00)00044-9. [DOI] [PubMed] [Google Scholar]
  37. Nair DN, Prasad R, Singhal N, Bhattacharjee M, Sudhakar R, Singh P, Thanumalayan S, Kiran U, Sharma Y, Sijwali PS. A conserved human DJ1-subfamily motif (DJSM) is critical for anti-oxidative and deglycase activities of Plasmodium falciparum DJ1. Molecular and Biochemical Parasitology. 2018;222:70–80. doi: 10.1016/j.molbiopara.2018.05.003. [DOI] [PubMed] [Google Scholar]
  38. Natkańska U, Skoneczna A, Sieńko M, Skoneczny M. The budding yeast orthologue of Parkinson’s disease-associated DJ-1 is a multi-stress response protein protecting cells against toxic glycolytic products. Biochimica et Biophysica Acta. Molecular Cell Research. 2017;1864:39–50. doi: 10.1016/j.bbamcr.2016.10.016. [DOI] [PubMed] [Google Scholar]
  39. Prasad M, Kataria P, Ningaraju S, Buddidathi R, Bankapalli K, Swetha C, Susarla G, Venkatesan R, D’Silva P, Shivaprasad PV. Double DJ-1 domain containing Arabidopsis DJ-1D is a robust macromolecule deglycase. The New Phytologist. 2022;236:1061–1074. doi: 10.1111/nph.18414. [DOI] [PubMed] [Google Scholar]
  40. Raupbach J, Ott C, Koenig J, Grune T. Proteasomal degradation of glycated proteins depends on substrate unfolding: Preferred degradation of moderately modified myoglobin. Free Radical Biology & Medicine. 2020;152:516–524. doi: 10.1016/j.freeradbiomed.2019.11.024. [DOI] [PubMed] [Google Scholar]
  41. Ray DM, Jennings EQ, Maksimovic I, Chai X, Galligan JJ, David Y, Zheng Q. Chemical labeling and enrichment of histone glyoxal adducts. ACS Chemical Biology. 2022;17:756–761. doi: 10.1021/acschembio.1c00864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Richarme G, Mihoub M, Dairou J, Bui LC, Leger T, Lamouri A. Parkinsonism-associated protein DJ-1/Park7 is a major protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues. The Journal of Biological Chemistry. 2015;290:1885–1897. doi: 10.1074/jbc.M114.597815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Richarme G, Liu C, Mihoub M, Abdallah J, Leger T, Joly N, Liebart J-C, Jurkunas UV, Nadal M, Bouloc P, Dairou J, Lamouri A. Guanine glycation repair by DJ-1/Park7 and its bacterial homologs. Science. 2017;357:208–211. doi: 10.1126/science.aag1095. [DOI] [PubMed] [Google Scholar]
  44. Rodrigues DC, Harvey EM, Suraj R, Erickson SL, Mohammad L, Ren M, Liu H, He G, Kaplan DR, Ellis J, Yang G. Methylglyoxal couples metabolic and translational control of Notch signalling in mammalian neural stem cells. Nature Communications. 2020;11:2018. doi: 10.1038/s41467-020-15941-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sambrook J, Russell DW. Preparation of plasmid DNA by alkaline lysis with SDS: maxipreparation. CSH Protocols. 2006;2006:pdb.prot4090. doi: 10.1101/pdb.prot4090. [DOI] [PubMed] [Google Scholar]
  46. Semchyshyn HM. Reactive carbonyl species in vivo: generation and dual biological effects. TheScientificWorldJournal. 2014;2014:417842. doi: 10.1155/2014/417842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Seo K, Ki SH, Shin SM. Methylglyoxal induces mitochondrial dysfunction and cell death in liver. Toxicological Research. 2014;30:193–198. doi: 10.5487/TR.2014.30.3.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Shaffer D, Rollins JA. Fluorescent polysome profiling in Caenorhabditis elegans. Bio-Protocol. 2020;10:e3742. doi: 10.21769/BioProtoc.3742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sharma N, Rao SP, Kalivendi SV. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson’s disease. Free Radical Biology & Medicine. 2019;135:28–37. doi: 10.1016/j.freeradbiomed.2019.02.014. [DOI] [PubMed] [Google Scholar]
  50. Smith AJ, Advani J, Brock DC, Nellissery J, Gumerson J, Dong L, Aravind L, Kennedy B, Swaroop A. GATD3A, a mitochondrial deglycase with evolutionary origins from gammaproteobacteria, restricts the formation of advanced glycation end products. BMC Biology. 2022;20:68. doi: 10.1186/s12915-022-01267-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839–840. doi: 10.1038/42166. [DOI] [PubMed] [Google Scholar]
  52. Subedi KP, Choi D, Kim I, Min B, Park C. Hsp31 of Escherichia coli K-12 is glyoxalase III. Molecular Microbiology. 2011;81:926–936. doi: 10.1111/j.1365-2958.2011.07736.x. [DOI] [PubMed] [Google Scholar]
  53. Sun F, Suttapitugsakul S, Xiao H, Wu R. Comprehensive analysis of protein glycation reveals its potential impacts on protein degradation and gene expression in human cells. Journal of the American Society for Mass Spectrometry. 2019;30:2480–2490. doi: 10.1007/s13361-019-02197-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Thornalley PJ. Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease. Drug Metabolism and Drug Interactions. 2008;23:125–150. doi: 10.1515/dmdi.2008.23.1-2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Toyoda Y, Erkut C, Pan-Montojo F, Boland S, Stewart MP, Müller DJ, Wurst W, Hyman AA, Kurzchalia TV. Products of the Parkinson’s disease-related glyoxalase DJ-1, D-lactate and glycolate, support mitochondrial membrane potential and neuronal survival. Biology Open. 2014;3:777–784. doi: 10.1242/bio.20149399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Tsai C-J, Aslam K, Drendel HM, Asiago JM, Goode KM, Paul LN, Rochet J-C, Hazbun TR. Hsp31 Is a stress response chaperone that intervenes in the protein misfolding process. The Journal of Biological Chemistry. 2015;290:24816–24834. doi: 10.1074/jbc.M115.678367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Vander Jagt DL, Hunsaker LA. Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chemico-Biological Interactions. 2003;143–144:341–351. doi: 10.1016/s0009-2797(02)00212-0. [DOI] [PubMed] [Google Scholar]
  58. Vicente Miranda H, Szego ÉM, Oliveira LMA, Breda C, Darendelioglu E, de Oliveira RM, Ferreira DG, Gomes MA, Rott R, Oliveira M, Munari F, Enguita FJ, Simões T, Rodrigues EF, Heinrich M, Martins IC, Zamolo I, Riess O, Cordeiro C, Ponces-Freire A, Lashuel HA, Santos NC, Lopes LV, Xiang W, Jovin TM, Penque D, Engelender S, Zweckstetter M, Klucken J, Giorgini F, Quintas A, Outeiro TF. Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies. Brain. 2017;140:1399–1419. doi: 10.1093/brain/awx056. [DOI] [PubMed] [Google Scholar]
  59. Videira PAQ, Castro-Caldas M. Linking glycation and glycosylation with inflammation and mitochondrial dysfunction in parkinson’s disease. Frontiers in Neuroscience. 2018;12:381. doi: 10.3389/fnins.2018.00381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Wang Y, Xu E, Musich PR, Lin F. Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neuroscience & Therapeutics. 2019;25:816–824. doi: 10.1111/cns.13116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Wei Y, Ringe D, Wilson MA, Ondrechen MJ. Identification of functional subclasses in the DJ-1 superfamily proteins. PLOS Computational Biology. 2007;3:e10. doi: 10.1371/journal.pcbi.0030010. [DOI] [PubMed] [Google Scholar]
  62. Wilson MA, St Amour CV, Collins JL, Ringe D, Petsko GA. The 1.8-A resolution crystal structure of YDR533Cp from Saccharomyces cerevisiae: A member of the DJ-1/ThiJ/PfpI superfamily. PNAS. 2004;101:1531–1536. doi: 10.1073/pnas.0308089100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wilson M. A. The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxidants & Redox Signaling. 2011;15:111–122. doi: 10.1089/ars.2010.3481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Yang K, Qiang D, Delaney S, Mehta R, Bruce WR, O’Brien PJ. Differences in glyoxal and methylglyoxal metabolism determine cellular susceptibility to protein carbonylation and cytotoxicity. Chemico-Biological Interactions. 2011;191:322–329. doi: 10.1016/j.cbi.2011.02.012. [DOI] [PubMed] [Google Scholar]
  65. Zheng Q, Omans ND, Leicher R, Osunsade A, Agustinus AS, Finkin-Groner E, D’Ambrosio H, Liu B, Chandarlapaty S, Liu S, David Y. Reversible histone glycation is associated with disease-related changes in chromatin architecture. Nature Communications. 2019;10:1289. doi: 10.1038/s41467-019-09192-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Zheng Q., Maksimovic I, Upad A, David Y. Non-enzymatic covalent modifications: a new link between metabolism and epigenetics. Protein & Cell. 2020;11:401–416. doi: 10.1007/s13238-020-00722-w. [DOI] [PMC free article] [PubMed] [Google Scholar]

Editor's evaluation

Agnieszka Chacinska 1

This paper reports the important discovery of a mechanism of cellular response to the reactive carbonyl species, which in yeast involves Hsp31, Hsp32, Hsp33, and Hsp34, all orthologs of DJ-1 protein, a determinant of Parkinson's disease. The evidence supporting the role of Hsp31-34 in preventing and repairing damage to mitochondria, proteins and nucleic acids by reactive carbonyl species is convincing. The study will be of interest to molecular cell biologists and beyond, as it helps to shed new light on the molecular basis of Parkinson's disease pathology.

Decision letter

Editor: Agnieszka Chacinska1
Reviewed by: Brian M Zid2, Carlo Vascotto3

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Decision letter after peer review:

[Editors’ note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.]

Thank you for submitting the paper "Saccharomyces cerevisiae DJ-1 paralogs maintain genome integrity through glycation repair of nucleic acids and proteins" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Carlo Vascotto (Reviewer #2).

Comments to the Authors:

We are sorry to say that, after consultation with the reviewers, we have decided that this work will not be considered further for publication by eLife.

The reviewers agree that in its current form the manuscript requires major revisions to strengthen the aspects that are new in this work, which will likely take considerably longer than a few months. The list of critical comments and suggestions to improve the manuscript is appended below. Given the high interest in the topic and the potential of the findings, we encourage you to consider eLife for the submission of a more mature version of the work.

Reviewer #1 (Recommendations for the authors):

In this study, Susarala and colleagues attempted to uncover the functional importance of 4 human DJ-1 paralogs in Saccharomyces cerevisiae. By utilizing yeast strains lacking different combinations of these paralogs and by re-introducing them individually via overexpression, they unequivocally answer the role of these DJ-1 homologs in protecting against different forms of glycation damage. Furthermore, their study offers mechanistic insight into how these paralogs both neutralize reactive carbonyl species and reverse glycation damage to DNA, RNA, and proteins. Finally, they show that these paralogs translocate to mitochondria during glycation stress, illustrating the important role of these homologs in protecting mitochondria from reactive carbonyl species.

Thus, this study firmly establishes the physiological role of the 4 yeast DJ-1 homologs Hsp31, Hsp32, Hsp33, and Hsp34. While these results have implications for how proteostatic stress is mitigated and proteostasis is maintained in Saccharomyces cerevisiae, they lack direct translatability to various disease models in which DJ-1 is suspected to play a physiological role. Moreover, the translocation of the paralogs to mitochondria during reactive carbonyl species stress is an interesting observation, but further studies are needed to fully elucidate the mechanistic importance of this process in different disease models.

1. For Figure 1A, given the translocation of the paralogs to mitochondria during glycation stress, it would be interesting to observe the growth of these strains on a non-fermentable carbon source.

2. For Figure 2J, why are the RNA glycation damage values for the various Hsp knockout strains significantly lower than Δ31 in Figure 2I? Given that these figures concern methylglyoxal-induced damage, shouldn't we expect the values to be more similar?

3. The in vitro activity assays are very well done, but it is the opinion of this reviewer that the results of the C138A mutants do not add significantly to the overall story. Perhaps these data are better suited for the supplement?

4. The confocal images in Figures 5I, 7, and 7-supplement 1 would benefit from the inclusion of rigorous quantification to show RAD52 foci formation and percent co-localization of the paralogs to mitochondria.

5. It is the opinion of the reviewer that the manuscript would benefit if Figure 7 —figure supplement 1 was somehow included in the main figure. Furthermore, it would be helpful if in the supplement it was shown that Hsp32, Hsp33, and Hsp34 do not translocate to mitochondria during methylglyoxal stress.

6. In the first paragraph of the discussion, you mention that Hsp33 has a different active site than Hsp31. Do you instead mean that Hsp32, Hsp33, and Hsp34 all have the same active site and that only Hsp31 has a different active site?

7. Lines 497-498 would benefit from the addition of citations.

8. On line 509, what do you mean by "stabilizes mitochondrial membrane potential"? Additional clarification and/or rephrasing would be helpful.

9. On lines 513-516, you highlight that the potential translocation of DJ-1 to mitochondria may help delay the progression of Parkinson's disease by attenuating glycation damage. However, this point warrants additional discussion and citations concerning how this may impact interactions of α-synuclein with mitochondria, and further how this may be important for the pathogenesis of Parkinson's disease.

10. On line 519, I would argue that the claim of conferring cytoprotection by preserving organellar integrity is unsubstantiated by the current study.

11. Lines 520-522 require citations.

12. It is the opinion of this reviewer that the Discussion section of this manuscript would benefit from the inclusion of a paragraph discussing both the limitations of the current study and potential avenues for follow-up studies.

Reviewer #2 (Recommendations for the authors):

With this study, Susarla et al. investigate a previously neglected family of yeast enzymes belonging to the DJ -1 superfamily of proteins. In particular, the authors focus on Hsp31 paralogs, which play a leading role in controlling the glycation of proteins and nucleic acids. The manuscript is logically organized and easy to read. The methodological approaches chosen are appropriate, and the data are presented logically and coherently, largely supporting the hypothesis.

The weaknesses that I noticed relate to:

1. The mitochondrial function of these proteins is not fully and adequately supported by the data presented.

2. Some controls necessary to support the experimental approach are missing.

3. The discrepancy between some images and the relative densitometric analysis.

In summary, the manuscript has a high degree of novelty, and the new findings greatly expand the current knowledge in the field.

Although the reported data are convincing, I think the authors should consider the following points to improve the quality of their work:

1. The impact of the results on mitochondrial maintenance is limited and not properly supported.

2. In Figure 7E, there are no markers showing that the analysis was performed on isolated mitochondria. The author should include at least one mitochondrial marker protein.

3. The sentence on page 21, line 505 "Interestingly, translocation of Hsp31 members into mitochondria substantially lowers the glycation of mitochondrial proteome and DNA,…" I cannot find any data showing a decrease in mtDNA glycation levels. The authors should measure the glycation level of isolated mtDNA under ΔQ and Hsp31 overexpression conditions.

4. Figure 2 G, H: I found no agreement between the image and relative densitometric analysis. e.g.: in panel G, the glycation level of DNA is reported to be 40-fold higher in Dglo1 than in WT. In panel I, an 8-fold increase is reported, but looking at the picture, it looks much more. The same is true for the other two panels (H and J). I also notice a discrepancy between the image and the bar graph in Figure 4C. The signal in samples 32 and 33 seems to me to be stronger than that in ΔQ. Since this is a representative image of biological replicates, it should also be representative of the data reported in the densitometric analysis. The authors should revise these data.

5. In Figure 3A-B, the authors use recombinant proteins to measure the enzymatic activities and kinetic parameters of Hsp31 paralogs. I suggest including a picture of an SDS-PAGE analysis of the recombinant proteins used.

Reviewer #3 (Recommendations for the authors):

The authors were trying to explore the mechanism of action of the DJ-1 paralogs Hsp31, Hsp32, Hsp33, and Hsp34 and whether there may be differences between these highly similar orthologs. They did a good job of showing that while for reactive carbonyl species, glyoxal, they behave similarly, but, for methylglyoxal, only Hsp31 was able to revert this damage.

My main criticism of the work is that for many of the other conclusions it is unclear how much this advances the field over previous work already published by this group and others. They have already previously published that Hsp31 has robust glyoxalase activity (Bankapalli et al. 2015). While others have shown that DJ-1 and its bacterial homologs can repair glycated nucleic acids and proteins (Richarme et al. 2017, Richarme et al. 2018). While an argument could be made that it is unclear if human DJ-1 and Hsp31 would have the same activity, they also previously showed that human DJ-1 can complement hsp31∆ (Bankapalli et al. 2015). They also mention how distribution to the mitochondria can alleviate glycation damage, but they already showed that DJ-1 orthologs redistribute to the mitochondria during stress (Bankapalli et al. 2015).

Another criticism is that some of their findings are overstated relative to the data they show here.

"…the glycation of RNA significantly reduced mRNA translation activity in the absence of yeast DJ-1 members". This is not directly shown. While they do see reduced mRNA translation activity while they see increased glycation of RNA, they have also shown that there are many levels of stress response induced by this treatment (DNA damage, mitochondrial stress). As a reduction of translation initiation is a common occurrence from a variety of stresses, it is unclear that it can be concluded that the reduced translational activity is due directly to the glycation of RNA and not a general stress response of the cell.

"DJ-1 orthologs provide robust organellar protection by redistributing into mitochondria to alleviate the glycation damage of mitochondrial DNA and proteins." "Here, we provide direct evidence of mitochondrial maintenance by yeast DJ-1 orthologs, effectively through robust redistribution under glycation stress." I would disagree that they show direct evidence that redistribution is necessary for the protective effects they see. While it is shown that these proteins relocalize to the mitochondria, it isn't shown that relocalization is required to protect the mitochondrial proteins. It could be that the glyoxalase-driven reduction of these reactive carbonyl species is sufficient to protect the mitochondria without translocation to the mitochondria.

To directly show that mitochondrial localization of Hsp31 is necessary to protect the mitochondria, the authors should repress relocalization to the mitochondria and test the effects on mitochondrial proteins. Do these proteins have a mitochondrial targeting sequence? What is known about how these proteins are targeted to the mitochondria?

[Editors’ note: further revisions were suggested prior to acceptance, as described below.]

Thank you for resubmitting your work entitled "Saccharomyces cerevisiae DJ-1 paralogs maintain genome integrity through glycation repair of nucleic acids and proteins" for further consideration by eLife. Your revised article has been evaluated by Detlef Weigel (Senior Editor) and a Reviewing Editor.

The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:

Specifically, reviewer 1 requests further improvements as outlined below, which may be addressed by text changes or experimentally, upon the authors' decision, and described in the point-by-point response.

However, it is critical that the authors thoroughly address points no 4 and 5.

Altogether, as you will see from the appended comments, the reviewers are impressed by the largely improved version of the manuscript.

Reviewer #1 (Recommendations for the authors):

1. First, I thank the authors for their thorough and thoughtful replies to our original critiques. I feel they have done an excellent job fully addressing our concerns, and I believe the manuscript is greatly strengthened as a result.

2. In Figure 8B, NAO is used to stain the total mitochondrial mass +/- GO treatment. Is it known whether or not the loss of Hsp31-34 paralogs has any effect on cardiolipin levels, which may affect the measurement of mitochondrial mass? Did you try using MitoTracker, or another membrane potential-independent dye?

3. In Figure 8D, you measure mitochondrial ATP levels after GO treatment. Of course, AAC would be exporting ATP during the isolation procedure. Have you attempted to instead measure cellular ATP levels after GO treatment, perhaps in a media with a non-fermentable carbon source?

4. In some of the figures, the number of independent biological replicates is listed (i.e., n = 3). However, other figures, such as Figure 5 and Figure 5-supplement 1, it is missing. Furthermore, for Figure 5—figure supplement 1G, it is unclear if the quantification from multiple images (> 3) is from one or more independent biological replicates. The review would find it helpful if all figures list the number of independent biological replicates performed.

5. Lastly, for Figure 8—figure supplement 1, in the text you mention that mitochondrial health is compromised in δ Q, but δ T also shows impaired growth on a non-fermentable carbon source.

Reviewer #2 (Recommendations for the authors):

They have improved the manuscript by including data that loss of the Hsp31 paralogs induced reduced growth in respiratory conditions as well as that loss of the paralogs leads to mitochondrial dysfunction and fragmentation. The authors have also improved their manuscript by reducing some of the claims they were making.

Reviewer #3 (Recommendations for the authors):

The authors have adequately addressed all the issues/concerns raised by the three reviewers and have implemented the manuscript accordingly.

In my opinion, the topic is relevant and the data presented are of high quality, compelling, and overall add to the current knowledge of DJ-1 orthologs as detoxifying enzymes against lesions caused by reactive carbonyl species on nucleic acids and proteins. As is often the case, new information on molecular mechanisms raises further questions, such as the molecular mechanisms responsible for mitochondrial transport or the relevance to human studies, but these could be addressed in future studies.

eLife. 2023 Aug 7;12:e88875. doi: 10.7554/eLife.88875.sa2

Author response


[Editors’ note: the authors resubmitted a revised version of the paper for consideration. What follows is the authors’ response to the first round of review.]

Comments to the Authors:

Reviewer #1 (Recommendations for the authors):

In this study, Susarala and colleagues attempted to uncover the functional importance of 4 human DJ-1 paralogs in Saccharomyces cerevisiae. By utilizing yeast strains lacking different combinations of these paralogs and by re-introducing them individually via overexpression, they unequivocally answer the role of these DJ-1 homologs in protecting against different forms of glycation damage. Furthermore, their study offers mechanistic insight into how these paralogs both neutralize reactive carbonyl species and reverse glycation damage to DNA, RNA, and proteins. Finally, they show that these paralogs translocate to mitochondria during glycation stress, illustrating the important role of these homologs in protecting mitochondria from reactive carbonyl species.

We thank the reviewer for summarising the critical highlights of our study.

Thus, this study firmly establishes the physiological role of the 4 yeast DJ-1 homologs Hsp31, Hsp32, Hsp33, and Hsp34. While these results have implications for how proteostatic stress is mitigated and proteostasis is maintained in Saccharomyces cerevisiae, they lack direct translatability to various disease models in which DJ-1 is suspected to play a physiological role. Moreover, the translocation of the paralogs to mitochondria during reactive carbonyl species stress is an interesting observation, but further studies are needed to fully elucidate the mechanistic importance of this process in different disease models.

Thank you for your response. We agree that the emerging functions of Hsp31 paralogs are fascinating and need further examination in human DJ-1 with desired model organisms to reveal its physiological significance. However, our study provides a possible mechanism of how human DJ-1 contributes to cellular protection during carbonyl toxicity. Indeed, the translocation of Hsp31 paralogs into mitochondria is interesting. Further experiments need to be performed to better understand the diverse response of DJ-1 and its mechanism to support mitochondrial health.

1. For Figure 1A, given the translocation of the paralogs to mitochondria during glycation stress, it would be interesting to observe the growth of these strains on a non-fermentable carbon source.

Thank you for your suggestion. We have performed the phenotypic growth analysis of all the strains from Figure 1A on a non-fermentable carbon source (glycerol), comparing it with dextrose (fermentable carbon source) media. This result was incorporated into the revised manuscript. Refer to Figure 8figure Supplement 1.

2. For Figure 2J, why are the RNA glycation damage values for the various Hsp knockout strains significantly lower than Δ31 in Figure 2I? Given that these figures concern methylglyoxal-induced damage, shouldn't we expect the values to be more similar?

We apologise for this mistake. The blot from figure 2I displayed a saturated signal, making it difficult to analyze the result. In the revised manuscript, it has been replaced with a blot having appropriate exposure, and the RNA glycation levels from Δ31 of figure 2I are almost similar to deletion strains of figure 2J, which is also supported by the densitometric graph.

3. The in vitro activity assays are very well done, but it is the opinion of this reviewer that the results of the C138A mutants do not add significantly to the overall story. Perhaps these data are better suited for the supplement?

We thank the reviewer for the valuable input. The macromolecular deglycation by the C138A mutant of Hsp31 and its paralogs are now moved to supplement data. Refer to Figure 5—figure supplement A-D and Figure 6—figure supplement A-D.

4. The confocal images in Figures 5I, 7, and 7-supplement 1 would benefit from the inclusion of rigorous quantification to show RAD52 foci formation and percent co-localization of the paralogs to mitochondria.

Thank you for the technical suggestion. We have quantitated the RAD52 foci formation from Figure 5I, and the graph is provided in the revised manuscript in Figure 5—figure supplement G. For percentage localization of Hsp31 paralogs into mitochondria from Figure 7 (A to D) and Figure 7-supplement 1, we performed westerns analysis without and with glyoxal and methylglyoxal treatments. Subsequently, the mitochondria were isolated and examined for the fold change in the localization of Hsp31 paralogs. These results are incorporated in the revised manuscript in Figure 7—figure supplement 1A and B.

5. It is the opinion of the reviewer that the manuscript would benefit if Figure 7 —figure supplement 1 was somehow included in the main figure. Furthermore, it would be helpful if in the supplement it was shown that Hsp32, Hsp33, and Hsp34 do not translocate to mitochondria during methylglyoxal stress.

We thank the reviewer for the constructive advice. Figure 7—figure supplement 1 is now included in Figure 7 E of the main figures. We performed microscopic visualization studies to show that Hsp32, Hsp33, and Hsp34 do not enrich in mitochondria during methylglyoxal stress. The results are presented in the revised manuscript. Refer to Figure 7—figure supplement 1 C to E.

6. In the first paragraph of the discussion, you mention that Hsp33 has a different active site than Hsp31. Do you instead mean that Hsp32, Hsp33, and Hsp34 all have the same active site and that only Hsp31 has a different active site?

We apologize for creating confusion in the statement. The line states that Hsp32, Hsp33, and Hsp34 have a similar active site, which differs from Hsp31. In the revised manuscript, we have changed the statement to the following “Since Hsp32 and Hsp34 are structurally uncharacterized, we considered overlapping structural features with Hsp33 for comparative analysis due to its solved crystal structure and close sequence similarity. Strikingly, Hsp32, Hsp33, and Hsp34 possess a similar active site that offers different substrate specificity than Hsp31.”

7. Lines 497-498 would benefit from the addition of citations.

Thank you for your suggestions. We have added a relevant citation at the end of the statement.

8. On line 509, what do you mean by "stabilizes mitochondrial membrane potential"? Additional clarification and/or rephrasing would be helpful.

We apologize for the inconvenience. The statement has been rephrased to the following in the revised manuscript “Moreover, such redistribution of the paralogs could elevate the glycolate synthesis from glyoxal, a critical antioxidant that maintains mitochondrial membrane potential during stress conditions and re-establishes redox balance by producing GSH”.

9. On lines 513-516, you highlight that the potential translocation of DJ-1 to mitochondria may help delay the progression of Parkinson's disease by attenuating glycation damage. However, this point warrants additional discussion and citations concerning how this may impact interactions of α-synuclein with mitochondria, and further how this may be important for the pathogenesis of Parkinson's disease.

Thank you for your critical insight. In the revised manuscript, we have discussed the interaction of α-synuclein with mitochondria and the potential effects of glycated α-synuclein in the pathological progression of Parkinson’s disease. Refer to line number 567-571.

10. On line 519, I would argue that the claim of conferring cytoprotection by preserving organellar integrity is unsubstantiated by the current study.

We apologize for the mistake. The word cytoprotection has been removed in the current version of the manuscript.

11. Lines 520-522 require citations.

We apologise for the inconvenience. We have provided appropriate citations at the end of the statement in the revised manuscript.

12. It is the opinion of this reviewer that the Discussion section of this manuscript would benefit from the inclusion of a paragraph discussing both the limitations of the current study and potential avenues for follow-up studies.

Thank you for your valuable suggestion. We have now included a paragraph at the end of the discussion section explaining the limitations of the current study and the need to discover new findings to address potential and emerging avenues in the field.

Reviewer #2 (Recommendations for the authors):

With this study, Susarla et al. investigate a previously neglected family of yeast enzymes belonging to the DJ -1 superfamily of proteins. In particular, the authors focus on Hsp31 paralogs, which play a leading role in controlling the glycation of proteins and nucleic acids. The manuscript is logically organized and easy to read. The methodological approaches chosen are appropriate, and the data are presented logically and coherently, largely supporting the hypothesis.

The weaknesses that I noticed relate to:

1. The mitochondrial function of these proteins is not fully and adequately supported by the data presented.

2. Some controls necessary to support the experimental approach are missing.

3. The discrepancy between some images and the relative densitometric analysis.

As per the reviewer’s suggestions, we have performed multiple sets of experiments to strengthen the role of Hsp31 paralogs in mitochondrial protection and maintenance, which has been elaborately described in response to comment 1 below. Also, the discrepancies in the images and the relative densitometric analysis have been corrected and incorporated in the revised manuscript.

In summary, the manuscript has a high degree of novelty, and the new findings greatly expand the current knowledge in the field.

Thank you for understanding the potential of our work and its additional contribution to the existing knowledge.

Although the reported data are convincing, I think the authors should consider the following points to improve the quality of their work:

1. The impact of the results on mitochondrial maintenance is limited and not properly supported.

We thank the reviewer for their critical analysis and suggestions. We have now included a large data set (refer to Figure 8) related to mitochondrial maintenance by Hsp31 paralogs. A comprehensive study investigating various parameters of mitochondria, as listed below, was performed:

  1. Phenotypic analysis on non-fermentable carbon source (glycerol) to decipher the involvement of Hsp31 paralogs in mitochondrial maintenance [Figure 8—figure supplement 1]

  2. Microscopic studies of mitochondrial morphologies to visualize altered mitochondrial network in the presence of glycation stress [Figure 8 A]

  3. Quantitative measurement of total and functional mitochondrial mass to investigate the effect of glycation toxicity on global mitochondrial content [Figure 8 B and C].

  4. Measurement of mitochondrial ATP levels to assess the role of Hsp31 paralogs in preserving mitochondrial integrity [Figure 8 D].

  5. Microscopic visualization of mitochondrial DNA to study the impact of glyoxal glycation on DNA maintenance in the absence of DJ-1 members [Figure 8 E].

2. In Figure 7E, there are no markers showing that the analysis was performed on isolated mitochondria. The author should include at least one mitochondrial marker protein.

Thank you for the insights. We have now included the western analysis of mitochondria used in Figure 7E to show its purity and quality. The mitochondria isolates were probed with Tim23 as mitochondrial control and Ydj-1 for cytosol control. Refer to Figure 7—figure supplement 1F.

3. The sentence on page 21, line 505 "Interestingly, translocation of Hsp31 members into mitochondria substantially lowers the glycation of mitochondrial proteome and DNA,…" I cannot find any data showing a decrease in mtDNA glycation levels. The authors should measure the glycation level of isolated mtDNA under ΔQ and Hsp31 overexpression conditions.

We thank the reviewer for the valuable suggestions. The glycation levels of mtDNA under ΔQ and Hsp31 overexpression conditions were measured from purified mitochondria, and the data (refer to Figure 7G) has been included in the revised manuscript.

4. Figure 2 G, H: I found no agreement between the image and relative densitometric analysis. e.g.: in panel G, the glycation level of DNA is reported to be 40-fold higher in Dglo1 than in WT. In panel I, an 8-fold increase is reported, but looking at the picture, it looks much more. The same is true for the other two panels (H and J). I also notice a discrepancy between the image and the bar graph in Figure 4C. The signal in samples 32 and 33 seems to me to be stronger than that in ΔQ. Since this is a representative image of biological replicates, it should also be representative of the data reported in the densitometric analysis. The authors should revise these data.

We apologize for the inconvenience due to densitometric discrepancies. In the current manuscript, we have re-quantitated the western blots and revised all the densitometric graphs, whose values are now comparable to representative images. Figure 4C is replaced with better quality blot and exposure, where the glycation levels of ΔQ is comparable to overexpression strains of 32, 33, and 34.

5. In Figure 3A-B, the authors use recombinant proteins to measure the enzymatic activities and kinetic parameters of Hsp31 paralogs. I suggest including a picture of an SDS-PAGE analysis of the recombinant proteins used.

Thank you for your suggestion. We have now included the image of the SDS-PAGE analysis of purified Hsp31 paralog proteins. Refer to Figure 3—figure supplement 1A.

Reviewer #3 (Recommendations for the authors):

The authors were trying to explore the mechanism of action of the DJ-1 paralogs Hsp31, Hsp32, Hsp33, and Hsp34 and whether there may be differences between these highly similar orthologs. They did a good job of showing that while for reactive carbonyl species, glyoxal, they behave similarly, but, for methylglyoxal, only Hsp31 was able to revert this damage.

We thank the reviewer for appreciating the work and describing the key highlights of our study.

My main criticism of the work is that for many of the other conclusions it is unclear how much this advances the field over previous work already published by this group and others. They have already previously published that Hsp31 has robust glyoxalase activity (Bankapalli et al. 2015).

We thank the reviewer for the critical analysis. The key highlights of the present study show are listed below for the first time.

  • We examined the enzymatic properties of the unexplored members of Hsp31 minifamily proteins, where Hsp32, Hsp33, and Hsp34 possess glyoxalase activity. At the same time, Hsp31 has glyoxalase and methylglyoxalase activity, suggesting that multiple paralogs of DJ-1 could aid enhanced protection.

  • We show that the absence of yeast DJ-1 members induces severe glycation of DNA, RNA, and protein, along with reduced mRNA translation activity under carbonyl stress.

  • Our studies indicate that DJ-1 members are involved in genome maintenance as their disruption upregulates DNA damage response and enhances mutation frequency.

  • Our report provides evidence of glycation repair pathways in S. cerevisiae. Furthermore, the paralogs have substrate preference enabling Hsp31 to deglycate methylglyoxal and glyoxal glycated macromolecules, while Hsp32, Hsp33, and Hsp34 are specific to glyoxal glycated substrates.

  • For the first time, we show that yeast DJ-1 members translocate into mitochondria during carbonyl stress. They also influence global mitochondrial content and ATP levels during glycation toxicity.

The reviewer refers to (Bankapalli et al.) where authors discovered methylglyoxalase activity of Hsp31 alone and its role in oxidative stress. In the current report, we have investigated more comprehensively the physiological relevance of the unexplored members (Hsp32, Hsp33, and Hsp34) of Hsp31 paralogs in protection against glycation stress essentially through enzymatic functions.

While others have shown that DJ-1 and its bacterial homologs can repair glycated nucleic acids and proteins (Richarme et al. 2017, Richarme et al. 2018). While an argument could be made that it is unclear if human DJ-1 and Hsp31 would have the same activity, they also previously showed that human DJ-1 can complement hsp31∆ (Bankapalli et al. 2015).

We thank the reviewer for the valuable response. Although human DJ-1 and Hsp31 share partial functional conservation under oxidative stress, as reported by Bankapalli et al. 2015, very few studies were performed to understand the role of human DJ-1 under carbonyl stress and its implications in mitochondrial functioning. The absence of Hsp31 paralogs collectively induces glycation damage of macromolecules and promotes mitochondrial impairments through altered mitochondrial morphology, loss of functional mitochondria, and depleted ATP levels. Refer to Figure 8.

In summary, our report gives insights into how hDJ-1 could govern cellular and organellar health during carbonyl toxicity, a leading factor for the progression of Parkinson’s disease. Human DJ-1 possibly contributes through reverting glycation damage of DNA, RNA, and proteins. Further, it might translocate into mitochondria under carbonyl stress to abrogate glyoxal toxicity and maintain functional mitochondria.

They also mention how distribution to the mitochondria can alleviate glycation damage, but they already showed that DJ-1 orthologs redistribute to the mitochondria during stress (Bankapalli et al. 2015).

Thank you for the response. The authors from Bankapalli et al. 2015 investigated the redistribution of Hsp31 alone into mitochondria during oxidative stress. On the other hand, our report highlights the mitochondrial translocation of all the Hsp31 members in response to glycation toxicity, together alleviating the glycation damage.

Another criticism is that some of their findings are overstated relative to the data they show here.

"the glycation of RNA significantly reduced mRNA translation activity in the absence of yeast DJ-1 members". This is not directly shown. While they do see reduced mRNA translation activity while they see increased glycation of RNA, they have also shown that there are many levels of stress response induced by this treatment (DNA damage, mitochondrial stress). As a reduction of translation initiation is a common occurrence from a variety of stresses, it is unclear that it can be concluded that the reduced translational activity is due directly to the glycation of RNA and not a general stress response of the cell.

We apologize for the mistake. Since there was enhanced RNA glycation, we investigated its effects on mRNA translation efficiency and observed a reduction. However, as the reviewer suggested, the attenuation in translation could be a general stress response. Therefore, we have rephrased the statement to the following “Moreover, in response to glycation stress, mRNA translation activity was significantly reduced in the absence of yeast DJ-1 members”.

"DJ-1 orthologs provide robust organellar protection by redistributing into mitochondria to alleviate the glycation damage of mitochondrial DNA and proteins." "Here, we provide direct evidence of mitochondrial maintenance by yeast DJ-1 orthologs, effectively through robust redistribution under glycation stress." I would disagree that they show direct evidence that redistribution is necessary for the protective effects they see. While it is shown that these proteins relocalize to the mitochondria, it isn't shown that relocalization is required to protect the mitochondrial proteins. It could be that the glyoxalase-driven reduction of these reactive carbonyl species is sufficient to protect the mitochondria without translocation to the mitochondria.

We thank the reviewer for the critical analysis of our work. We observed a 2-3-fold increase in mitochondrial translocation of Hsp31 paralogs during carbonyl stress, which may abrogate macromolecular glycation (Figure 7—figure supplement 1A, E). However, as the reviewer pointed out, we need to perform extensive studies in the future to understand the localization mechanism of Hsp31 paralogs and their relevance in providing mitochondrial protection. Moreover, we have rephrased the sentence in the revised manuscript. Refer to lines 551-553.

To directly show that mitochondrial localization of Hsp31 is necessary to protect the mitochondria, the authors should repress relocalization to the mitochondria and test the effects on mitochondrial proteins. Do these proteins have a mitochondrial targeting sequence? What is known about how these proteins are targeted to the mitochondria?

Thank you for your critical question and suggestion. This has been a debate over the past 2 decades on how DJ-1 translocates into the mitochondrial compartment without having a welldefined N-terminal targeting sequence (Kojima et al.; Maita et al.). However, it is not surprising that many proteins show a dual localization under specific circumstances (such as oxidative stress, glyoxal stress), presumably by forming a complex with the resident mitochondrial proteins or due to posttranslational modifications. We believe that Hsp31 paralogs from yeast exhibit a similar phenotype (Elliott and Volkert; Heo et al.).

By considering reviewer suggestions constructively, we made several attempts to address this question past 6 months. The following are salient features of our findings:

Considering the existing literature and information available in online databases, strikingly, there is no evidence of MTS in yeast Hsp31 paralogs, and their translocation mechanism needs to be better studied. On the other hand, mutations in the N-terminal region of hDJ-1 affect mitochondrial translocation (Maita et al.).

Based on sequence alignment, we attempted to make several mutants (in combination) on the N-terminal region of Hsp31 and truncated N-terminal 12 residues. Subsequently, they were tested for phenotype and mitochondrial redistribution by probing isolated mitochondria from cells treated with methylglyoxal. Upon Western analysis, we observed an altered localization pattern in the Hsp31 mutants, comparable to WT Hsp31, but no repression was observed.

Moreover, the mutants showed enhanced localization of the protein in the absence of MG stress which is intriguing See Author response image 1, right K4A and K5A (lane 2 and 3) mutants compared to WT (lane 1). This suggests that the N-terminal residues play a role in redistributing the Hsp31 into the mitochondria. Moreover, we attempted to delete the protein's N terminal portion (truncated) to test the hypothesis. However, we could not detect the N-terminal truncated Hsp31 through the Western analysis.

Author response image 1.

Author response image 1.

However, elucidating the exact mechanism of how the N-terminal sequence regulates mitochondrial entry will be a larger question that requires a large time frame in the future.

ReferencesBankapalli, K. et al. "Robust Glyoxalase Activity of Hsp31, a Thij/Dj-1/Pfpi Family Member Protein, Is Critical for Oxidative Stress Resistance in Saccharomyces cerevisiae." J

Biol Chem, vol. 290, no. 44, 2015, pp. 26491-26507, doi:10.1074/jbc.M115.673624.

Elliott, N. A. and M. R. Volkert. "Stress Induction and Mitochondrial Localization of Oxr1 Proteins in Yeast and Humans." Mol Cell Biol, vol. 24, no. 8, 2004, pp. 3180-3187, doi:10.1128/mcb.24.8.3180-3187.2004.

Heo, J. M. et al. "A Stress-Responsive System for Mitochondrial Protein Degradation." Mol Cell, vol. 40, no. 3, 2010, pp. 465-480, doi:10.1016/j.molcel.2010.10.021.

Kojima, W. et al. "Unexpected Mitochondrial Matrix Localization of Parkinson's DiseaseRelated Dj-1 Mutants but Not Wild-Type Dj-1." Genes Cells, vol. 21, no. 7, 2016, pp. 772-788, doi:10.1111/gtc.12382.

Maita, C. et al. "Monomer Dj-1 and Its N-Terminal Sequence Are Necessary for Mitochondrial Localization of Dj-1 Mutants." PLoS One, vol. 8, no. 1, 2013, p. e54087, doi:10.1371/journal.pone.0054087.

[Editors’ note: what follows is the authors’ response to the second round of review.]

The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:

Specifically, reviewer 1 requests further improvements as outlined below, which may be addressed by text changes or experimentally, upon the authors' decision, and described in the point-by-point response.

However, it is critical that the authors thoroughly address points no 4 and 5.

Altogether, as you will see from the appended comments, the reviewers are impressed by the largely improved version of the manuscript.

Reviewer #1 (Recommendations for the authors):

1. First, I thank the authors for their thorough and thoughtful replies to our original critiques. I feel they have done an excellent job fully addressing our concerns, and I believe the manuscript is greatly strengthened as a result.

We are grateful for such a response. We thank the reviewer for critical comments and insightful suggestions, which helped in reorganizing and strengthening various aspects of the manuscript.

2. In Figure 8B, NAO is used to stain the total mitochondrial mass +/- GO treatment. Is it known whether or not the loss of Hsp31-34 paralogs has any effect on cardiolipin levels, which may affect the measurement of mitochondrial mass? Did you try using MitoTracker, or another membrane potential-independent dye?

Thank you for your comment. NAO dye was used to determine the total mitochondrial mass in Figure 8B, which stains the cardiolipin of mitochondria. However, there are no studies performed to estimate the cardiolipin levels in the absence of Hsp31 paralogs and hDJ-1. Besides, our microscopic data from Figure 8A, where cells are episomally expressing mCherry in a plasmid, also indicates that loss of Hsp31 paralogs alters mitochondrial content.

As suggested by the reviewer, we have utilized MitoTracker deep red, a potential dependent stain that is independent of cardiolipin levels, to measure mitochondrial mass (Xiao et al.). Since it is potential dependent, we observed a similar result comparable to TMRE staining (see Author response image 2, compare with Figure 8C), with ∆Q showing a higher fold of mitochondrial dysfunction than WT in the presence of GO treatment.

Author response image 2. Estimating mitochondrial mass through MitoTracker deep red.

Author response image 2.

WT and ∆Q cells from the mid-log phase were incubated without or with GO, and cells were stained with MitoTracker deep red, followed by flow cytometric analysis.

3. In Figure 8D, you measure mitochondrial ATP levels after GO treatment. Of course, AAC would be exporting ATP during the isolation procedure. Have you attempted to instead measure cellular ATP levels after GO treatment, perhaps in a media with a non-fermentable carbon source?

Thank you for the suggestion. We did not measure the cellular ATP levels since the global ATP pool is contributed through multiple biochemical pathways besides mitochondrial respiration (Dunn and Grider). Moreover, it is difficult to conclude glycation-induced mitochondrial damage from an altered total cellular ATP pool. Therefore, we isolated mitochondria devoid of cytosolic fraction and estimated ATP levels which directly correlate to mitochondrial respiration and health.

4. In some of the figures, the number of independent biological replicates is listed (i.e., n = 3). However, other figures, such as Figure 5 and Figure 5-supplement 1, it is missing. Furthermore, for Figure 5—figure supplement 1G, it is unclear if the quantification from multiple images (> 3) is from one or more independent biological replicates. The review would find it helpful if all figures list the number of independent biological replicates performed.

We apologize for the inconvenience. In the revised manuscript, we have included the respective number of independent biological replicates in their corresponding figure legends.

5. Lastly, for Figure 8—figure supplement 1, in the text you mention that mitochondrial health is compromised in δ Q, but δ T also shows impaired growth on a non-fermentable carbon source.

We apologize for our mistake. We have incorporated the following statement in the revised manuscript “Although we observe no growth difference in dextrose media, the collective absence of Hsp31 paralogs in ΔT and ΔQ induced sensitivity to glycerol media”.

Reviewer #2 (Recommendations for the authors):

They have improved the manuscript by including data that loss of the Hsp31 paralogs induced reduced growth in respiratory conditions as well as that loss of the paralogs leads to mitochondrial dysfunction and fragmentation. The authors have also improved their manuscript by reducing some of the claims they were making.

We thank the reviewer for appreciating our work and giving us the opportunity to corroborate the role of hsp31 paralogs in mitochondrial maintenance. These recommendations further strengthened our findings and contributions to the existing knowledge of DJ-1 family proteins.

Reviewer #3 (Recommendations for the authors):

The authors have adequately addressed all the issues/concerns raised by the three reviewers and have implemented the manuscript accordingly.

In my opinion, the topic is relevant and the data presented are of high quality, compelling, and overall add to the current knowledge of DJ-1 orthologs as detoxifying enzymes against lesions caused by reactive carbonyl species on nucleic acids and proteins. As is often the case, new information on molecular mechanisms raises further questions, such as the molecular mechanisms responsible for mitochondrial transport or the relevance to human studies, but these could be addressed in future studies.

We greatly appreciate the reviewer’s thoughtful insight into the mechanism of mitochondrial translocation of Hsp31 paralogs. We agree with the reviewer that the translocation mechanism is indeed interesting, and the molecular mechanisms could be perused in future studies involving disease models.

References

Dunn, J. and M. H. Grider. "Physiology, Adenosine Triphosphate." Statpearls, StatPearls Publishing Copyright 2023, StatPearls Publishing LLC., 2023.

Xiao, B. et al. "Flow Cytometry-Based Assessment of Mitophagy Using Mitotracker." Front Cell Neurosci, vol. 10, 2016, p. 76, doi:10.3389/fncel.2016.00076.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Figure 1—source data 1. Source data for Figure 1B contains raw image of western blot and densitometric values for graph.
    Figure 1—source data 2. Source data for Figure 1C contains raw image of western blot and densitometric values for graph.
    Figure 1—source data 3. Source data for Figure 1D contains raw image of western blot and densitometric values for graph.
    Figure 1—source data 4. Source data for Figure 1E contains raw image of western blot and densitometric values for graph.
    Figure 1—figure supplement 1—source data 1. Source data for Figure 1—figure supplement 1B contains raw image of western blot.
    Figure 1—figure supplement 1—source data 2. Source data for Figure 1—figure supplement 1C contains raw image of western blot.
    Figure 2—source data 1. Source data for Figure 2A contains raw image of western blot and densitometric values for graph.
    Figure 2—source data 2. Source data for Figure 2B contains raw image of western blot and densitometric values for graph.
    Figure 2—source data 3. Source data for Figure 2C contains raw image of western blot and densitometric values for graph.
    Figure 2—source data 4. Source data for Figure 2D contains raw image of western blot and densitometric values for graph.
    Figure 2—source data 5. Source data for Figure 2E contains densitometric values for graph.
    Figure 2—source data 6. Source data for Figure 2F contains densitometric values for graph.
    Figure 2—source data 7. Source data for Figure 2G contains raw image of western blot and densitometric values for graph.
    Figure 2—source data 8. Source data for Figure 2H contains raw image of western blot and densitometric values for graph.
    Figure 2—source data 9. Source data for Figure 2I contains raw image of western blot and densitometric values for graph.
    Figure 2—source data 10. Source data for Figure 2J contains raw image of western blot and densitometric values for graph.
    Figure 2—figure supplement 1—source data 1. Source data for Figure 2—figure supplement 1A contains raw image of western blot.
    Figure 2—figure supplement 1—source data 2. Source data for Figure 2—figure supplement 1B contains raw image of western blot.
    Figure 3—source data 1. Source data for Figure 3A contains densitometric values for graph.
    Figure 3—source data 2. Source data for Figure 3B contains densitometric values for graph.
    Figure 3—source data 3. Source data for Figure 3D contains raw image of western blot and densitometric values for graph.
    Figure 3—source data 4. Source data for Figure 3E contains raw image of western blot and densitometric values for graph.
    Figure 3—source data 5. Source data for Figure 3F contains raw image of western blot and densitometric values for graph.
    Figure 3—source data 6. Source data for Figure 3G contains densitometric values for graph.
    Figure 3—figure supplement 1—source data 1. Source data for Figure 3—figure supplement 1A contains raw image of SDS-PAGE.
    Figure 3—figure supplement 1—source data 2. Source data for Figure 3—figure supplement 1C contains raw image of western blot.
    Figure 3—figure supplement 1—source data 3. Source data for Figure 3—figure supplement 1D contains raw image of western blot.
    Figure 3—figure supplement 1—source data 4. Source data for Figure 3—figure supplement 1E contains densitometric values for graph.
    Figure 4—source data 1. Source data for Figure 4A contains densitometric values for graph.
    Figure 4—source data 2. Source data for Figure 4C contains raw image of western blot and densitometric values for graph.
    Figure 4—source data 3. Source data for Figure 4D contains raw image of western blot and densitometric values for graph.
    Figure 4—source data 4. Source data for Figure 4E contains raw image of western blot and densitometric values for graph.
    Figure 4—source data 5. Source data for Figure 4F densitometric values for graph.
    Figure 5—source data 1. Source data for Figure 5B contains raw image of agarose gel.
    Figure 5—source data 2. Source data for Figure 5C contains raw image of agarose gel.
    Figure 5—source data 3. Source data for Figure 5D contains raw image of western blot.
    Figure 5—source data 4. Source data for Figure 5E contains raw image of western blot.
    Figure 5—source data 5. Source data for Figure 5H contains raw image of western blot.
    Figure 5—source data 6. Source data for Figure 5F contains multiple sequence alignment highlighting the mutations.
    Figure 5—figure supplement 1—source data 1. Source data for Figure 5—figure supplement 1A contains raw image of agarose gel.
    Figure 5—figure supplement 1—source data 2. Source data for Figure 5—figure supplement 1B contains raw image of agarose gel.
    Figure 5—figure supplement 1—source data 3. Source data for Figure 5—figure supplement 1C contains raw image of western blot.
    Figure 5—figure supplement 1—source data 4. Source data for Figure 5—figure supplement 1D contains raw image of western blot.
    Figure 5—figure supplement 1—source data 5. Source data for Figure 5—figure supplement 1G contains densitometric values of graph.
    Figure 6—source data 1. Source data for Figure 6B contains raw image of agarose gel.
    Figure 6—source data 2. Source data for Figure 6C contains raw image of agarose gel.
    Figure 6—source data 3. Source data for Figure 6D contains raw image of western blot.
    Figure 6—source data 4. Source data for Figure 6E contains raw image of western blot.
    Figure 6—source data 5. Source data for Figure 6F contains multiple sequence alignment highlighting the mutations.
    Figure 6—figure supplement 1—source data 1. Source data for Figure 6—figure supplement 1A contains raw image of agarose gel.
    Figure 6—figure supplement 1—source data 2. Source data for Figure 6—figure supplement 1B contains raw image of agarose gel.
    Figure 6—figure supplement 1—source data 3. Source data for Figure 6—figure supplement 1C contains raw image of western blot.
    Figure 6—figure supplement 1—source data 4. Source data for Figure 6—figure supplement 1D contains raw image of western blot.
    Figure 7—source data 1. Source data for Figure 7F contains raw image of western blot and densitometric values for graph.
    Figure 7—source data 2. Source data for Figure 7G contains raw image of western blot and densitometric values for graph.
    Figure 7—figure supplement 1—source data 1. Source data for Figure 7—figure supplement 1A contains raw image of western blot and densitometric values for graph.
    Figure 7—figure supplement 1—source data 2. Source data for Figure 7—figure supplement 1B contains raw image of western blot and densitometric values for graph.
    Figure 7—figure supplement 1—source data 3. Source data for Figure 7—figure supplement 1F contains raw image of western blot.
    Figure 8—source data 1. Source data for Figure 8B contains densitometric values for graph.
    Figure 8—source data 2. Source data for Figure 8C contains densitometric values for graph.
    Figure 8—source data 3. Source data for Figure 8D contains densitometric values for graph.
    Supplementary file 1. List of strains, primers, and plasmids used in this study.
    elife-88875-supp1.docx (30KB, docx)
    MDAR checklist

    Data Availability Statement

    All data generated or analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for all the Figures and Figure Supplements.


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES